3e6f:A     (SER2) to   (GLY175)  MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND A VARIANT PEPTIDE, PA9, FROM THE HUMAN IMMUNODEFICIENCY VIRUS (BAL) ENVELOPE GLYCOPROTEIN 120  |   COMPLEX (HISTOCOMPATIBILITY-ANTIGEN), GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, ENVELOPE PROTEIN, IMMUNE SYSTEM 
3e6h:A     (SER2) to   (ASN174)  MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND A VARIANT PEPTIDE, PI10, FROM THE HUMAN IMMUNODEFICIENCY VIRUS (BAL) ENVELOPE GLYCOPROTEIN 120  |   COMPLEX (HISTOCOMPATIBILITY-ANTIGEN), GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, ENVELOPE PROTEIN, IMMUNE SYSTEM 
3rl1:A     (GLY1) to   (ASN174)  HIV RT DERIVED PEPTIDE COMPLEXED TO HLA-A*0301  |   HLA-A*0301, CD8+ T CELL IMMUNITY, HIV DERIVED PEPTIDES, IMMUNE SYSTEM 
3rl2:A     (GLY1) to   (GLY175)  HIV NEF DERIVED PEPTIDE NEF73 COMPLEXED TO HLA-A*0301  |   HLA-A*0301, CD8+ T CELL IMMUNITY, HIV DERIVED PEPTIDES, IMMUNE SYSTEM 
1a1n:A     (SER2) to   (ASN174)  MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1  |   MAJOR HISTOCOMPATIBILITY ANTIGEN, MHC, HLA, HLA-B3501, HIV, NEF, COMPLEX (ANTIGEN/PEPTIDE) 
1a9e:A     (SER2) to   (ASN174)  DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA- B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS  |   MHC CLASS I, HISTOCOMPATIBILITY COMPLEX, HLA B3501, COMPLEX (MHC CLASS I/PEPTIDE) 
4wj5:D     (GLY1) to   (ASN174)  STRUCTURE OF HLA-A2 IN COMPLEX WITH AN ALTERED PEPTIDE LIGANDS BASED ON MART-1 VARIANT EPITOPE  |   ANTIGEN PRESENTATION, MAJOR HISTOCOMPATIBILITY COMPLEX, HLA-A2 ANTIGEN, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM 
2av1:D     (TYR7) to   (GLY175)  CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THE HEAVY CHAIN.  |   TAX PEPTIDE, MHC, MUTATED HLA-A2, E63Q, K66A, IMMUNE SYSTEM 
2av7:A     (TYR7) to   (ASN174)  CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVY CHAIN.  |   TAX PEPTIDE, MHC, MUTATED HLA-A2, K66A., IMMUNE SYSTEM 
1agb:A     (SER2) to   (GLY175)  ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGRKKYKL-3R MUTATION)  |   HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX 
1agd:A     (SER2) to   (GLY175)  ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYKL-INDEX PEPTIDE)  |   HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX 
1age:A     (SER2) to   (ASN174)  ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYRL-7R MUTATION)  |   HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX 
2axf:A     (SER2) to   (GLY175)  THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION  |   IMMUNE RESPONSE, PMHC, IMMUNE SYSTEM/GENE REGULATION COMPLEX 
1akj:A     (GLY1) to   (ASN174)  COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL CORECEPTOR CD8  |   T-CELL, GLYCOPROTEIN, SIGNAL, COMPLEX, IMMUNOLOGY, COMPLEX (MHC I/PEPTIDE/CD8) 
3rwd:A     (TYR7) to   (LYS176)  RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-IW11  |   ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM 
3rwg:A     (SER2) to   (GLU161)  RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-MW9  |   ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM 
3rwh:A     (TYR7) to   (GLY175)  RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-MF8  |   ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM 
3rwi:A     (GLY1) to   (GLY162)  RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-GW10  |   ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM 
3rwj:A     (GLY1) to   (LYS176)  RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-HW8  |   ANTIGENIC PEPTIDES, T LYMPHOCYTES, IMMUNE RESPONSE, IMMUNE SYSTEM 
1ao7:A     (TYR7) to   (GLY175)  COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201  |   CLASS I MHC, T-CELL RECEPTOR, VIRAL PEPTIDE, COMPLEX (MHC-VIRAL PEPTIDE-RECEPTOR, COMPLEX (MHC-VIRAL PEPTIDE-RECEPTOR) COMPLEX 
1b0g:A     (GLY1) to   (LYS176)  CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2- MICROGLOBULIN/PEPTIDE P1049 COMPLEX  |   CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)-BETA 2-MICROGLOBULIN- PEPTIDE P1049 COMPLEX, HISTOCOMPATIBILITY ANTIGEN 
1b0g:D     (GLY1) to   (LYS176)  CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2- MICROGLOBULIN/PEPTIDE P1049 COMPLEX  |   CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)-BETA 2-MICROGLOBULIN- PEPTIDE P1049 COMPLEX, HISTOCOMPATIBILITY ANTIGEN 
4wu5:A     (GLY1) to   (LYS176)  HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(WT)  |   IMMUNE RESPONSE, IMMUNE SYSTEM, HIV-1, NEF, HLA-A24, MHC CLASS I 
4wu7:D     (GLY1) to   (ASN174)  HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(2F)  |   IMMUNOGLOBURIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM, HIV-1, NEF, HLA-A24, MHC CLASS I 
4wuu:A     (TYR7) to   (ASN174)  STRUCTURE OF ESK1 IN COMPLEX WITH HLA-A*0201/WT1  |   ANTIBODY, MHC 1, WT1, HLA-A*0201, IMMUNE SYSTEM 
1b0r:A     (SER2) to   (GLU161)  CRYSTAL STRUCTURE OF HLA-A*0201 COMPLEXED WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP  |   HLA-A2, ANTIGENIC PEPTIDES, CLASS I MHC MOLECULES, HLA-A2 COMPLEXES, HYDROGEN BONDS, PROTEIN STRUCTURE, SIGNALING PROTEIN 
3es6:A     (ASP5) to   (LYS175)  CRYSTAL STRUCTURE OF THE NOVEL COMPLEX FORMED BETWEEN ZINC 2- GLYCOPROTEIN (ZAG) AND PROLACTIN INDUCIBLE PROTEIN (PIP) FROM HUMAN SEMINAL PLASMA  |   MAJOR HISTOCOMPATIBILITY COMPLEX, PROTEIN-PROTEIN COMPLEX, PROLACTIN INDUCIBLE PROTEIN, ZINC 2-GLYCOPROTEIN, ZAG-PIP COMPLEX, GLYCOPROTEIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ACTIN-BINDING, CELL ADHESION 
3ery:A     (GLY1) to   (ASN174)  DIFFERENT THERMODYNAMIC BINDING MECHANISMS AND PEPTIDE FINE SPECIFICITIES ASSOCIATED WITH A PANEL OF STRUCTURALLY SIMILAR HIGH-AFFINITY T CELL RECEPTORS  |   IMMUNE SYSTEM, MHC, PEPTIDE RECOGNITION 
1bii:A     (GLY1) to   (ASN176)  THE CRYSTAL STRUCTURE OF H-2DD MHC CLASS I IN COMPLEX WITH THE HIV-1 DERIVED PEPTIDE P18-110  |   COMPLEX (MHC I/PEPTIDE), MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I DD, TRANSMEMBRANE, GLYCOPROTEIN 
2bnq:A     (TYR7) to   (LEU160)  STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES  |   IMMUNE SYSTEM/RECEPTOR, IMMUNE SYSTEM/RECEPTOR/COMPLEX, TCR, MHC, IMMUNODOMINANCE, FLU, COMPLEX, PEPTIDE, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, POLYMORPHISM, T-CELL, RECEPTOR, SUPERAGONIST PEPTIDE T-CELL VACCINES 
1bqh:A     (GLY1) to   (ARG181)  MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8  |   T-CELL, CORECEPTOR, GLYCOPROTEIN, COMPLEX, IMMUNOLOGY, ANTIGEN, IMMUNE SYSTEM 
2bsr:A     (TYR7) to   (GLY175)  CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705  |   IMMUNE SYSTEM/PEPTIDE, MHC, HLA-B27, HUMAN EBV, HIV, GLYCOPROTEIN, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, NUCLEAR PROTEIN, COMPLEX (ANTIGEN/PEPTIDE) 
2bss:A     (TYR7) to   (ASN174)  CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705  |   IMMUNE SYSTEM/PEPTIDE, COMPLEX (ANTIGEN/PEPTIDE), IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), MHC HLA-B27, HUMAN EBV HIV, COMPLEX ANTIGEN PEPTIDE 
2bst:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705  |   IMMUNE SYSTEM-PEPTIDE COMPLEX, MHC, HLA-B27, HUMAN EBV, HIV, FLU, GLYCOPROTEIN, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, COMPLEX (ANTIGEN/PEPTIDE), VIRAL NUCLEOPROTEIN 
2bvo:A     (SER2) to   (GLY175)  STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION  |   GLYCOPROTEIN/PEPTIDE, MHC, HLA-B57, LTNP HIV-1, GLYCOPROTEIN/PEPTIDE COMPLEX, MHC I, POLYMORPHISM, SIGNAL, TRANSMEMBRANE, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID 
2bvp:A     (GLY1) to   (ASN174)  STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION  |   GLYCOPROTEIN/PEPTIDE, MHC, HLA-B57, LTNP, HIV-1, GLYCOPROTEIN, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN/PEPTIDE COMPLEX, IMMUNE RESPONSE 
4hwz:A     (GLY1) to   (ASN174)  STRUCTURE OF HLA-A68 COMPLEXED WITH AN HIV DERIVED PEPTIDE  |   HLA MOLECULES, PEPTIDE PRESENTATION, IMMUNE SYSTEM 
1oga:A     (GLY1) to   (LYS176)  A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.  |   IMMUNE SYSTEM/RECEPTOR, IMMUNE SYSTEM/RECEPTOR/COMPLEX, TCR, MHC, IMMUNODOMINANCE, FLU, COMPLEX, PEPTIDE, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, POLYMORPHISM, T-CELL, RECEPTOR 
1ogt:A     (SER2) to   (LYS176)  CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)  |   IMMUNE SYSTEM/COMPLEX, IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2705 
4i4w:A     (SER2) to   (ASN174)  PEPTIDE LENGTH DETERMINES THE OUTCOME OF T CELL RECEPTOR/PEPTIDE-MHCI ENGAGEMENT  |   MHC I FOLD, ANTIGEN PRESENTATION, T-CELL RECEPTOR, IMMUNE SYSTEM 
3fqn:A     (GLY1) to   (ASN174)  PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES  |   IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE 
3fqt:A     (GLY1) to   (LYS176)  PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES  |   IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE 
3fqu:A     (GLY1) to   (LYS176)  PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES  |   IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE 
3fqw:A     (GLY1) to   (ASN174)  PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES  |   IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE 
3fqx:A     (GLY1) to   (ASN174)  PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES  |   IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE 
3fru:A     (GLU2) to   (GLY172)  NEONATAL FC RECEPTOR, PH 6.5  |   COMPLEX (IMMUNOGLOBULIN-BINDING PROTEIN), COMPLEX (IMMUNOGLOBULIN- BINDING PROTEIN) COMPLEX 
3fru:E     (GLU2) to   (GLY172)  NEONATAL FC RECEPTOR, PH 6.5  |   COMPLEX (IMMUNOGLOBULIN-BINDING PROTEIN), COMPLEX (IMMUNOGLOBULIN- BINDING PROTEIN) COMPLEX 
3ft2:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF A CITRULLINE PEPTIDE VARIANT OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1 IN COMPLEX WITH HLA- A2  |   HLA, HUMAN MINOR H ANTIGENS, ANTIGEN PROCESSING, ANTIGEN PRESENTATION, IMMUNE RESPONSE, IMMUNOGENICITY, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, GRAFT REJECTION, HOST-VERSUS-GRAFT DISEASE, GRAFT-VERSUS- TUMOR IMMUNE SYSTEM 
3ft3:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1HIS IN COMPLEX WITH HLA-A2  |   HLA, HUMAN MINOR H ANTIGENS, ANTIGEN PROCESSING, ANTIGEN PRESENTATION, IMMUNE RESPONSE, IMMUNOGENICITY, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, GRAFT REJECTION, HOST-VERSUS-GRAFT DISEASE, GRAFT-VERSUS- TUMOR IMMUNE SYSTEM 
3ft4:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1ARG IN COMPLEX WITH HLA-A2  |   HLA, HUMAN MINOR H ANTIGENS, ANTIGEN PROCESSING, ANTIGEN PRESENTATION, IMMUNE RESPONSE, IMMUNOGENICITY, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, GRAFT REJECTION, HOST-VERSUS-GRAFT DISEASE, GRAFT-VERSUS- TUMOR IMMUNE SYSTEM 
2c7u:A     (GLY1) to   (LYS176)  CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE.  |   GLYCOPROTEIN-PEPTIDE COMPLEX, MHC, TCR, HLA-A2, HIV, GLYCOPROTEIN, IMMUNE RESPONSE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN/PEPTIDE COMPLEX, AIDS 
2c7u:D     (TYR7) to   (GLY175)  CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE.  |   GLYCOPROTEIN-PEPTIDE COMPLEX, MHC, TCR, HLA-A2, HIV, GLYCOPROTEIN, IMMUNE RESPONSE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN/PEPTIDE COMPLEX, AIDS 
1p7q:A     (GLY1) to   (HIS151)  CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-1, A HOST AND VIRAL MHC RECEPTOR  |   HLA-A2/LIR-1 COMPLEX, IMMUNE SYSTEM 
2cik:A     (SER2) to   (LYS176)  INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM CYTOCHROME P450.  |   IMMUNE SYSTEM/PEPTIDE, ANTIGEN/PEPTIDE COMPLEX, MAJOR HISTOCOMPATIBILITY ANTIGEN, HUMAN, MHC, HLA, HLA-B3501, EBV, ALLO-LIGAND, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID 
1de4:A     (ARG4) to   (LYS151)  HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR  |   HFE, HEREDITARY HEMOCHROMATOSIS, MHC CLASS I, TRANSFERRIN RECEPTOR, METAL TRANSPORT INHIBITOR-RECEPTOR COMPLEX 
1de4:D     (ARG4) to   (LYS151)  HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR  |   HFE, HEREDITARY HEMOCHROMATOSIS, MHC CLASS I, TRANSFERRIN RECEPTOR, METAL TRANSPORT INHIBITOR-RECEPTOR COMPLEX 
1de4:G     (ARG4) to   (LYS151)  HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR  |   HFE, HEREDITARY HEMOCHROMATOSIS, MHC CLASS I, TRANSFERRIN RECEPTOR, METAL TRANSPORT INHIBITOR-RECEPTOR COMPLEX 
2clr:D     (GLY1) to   (LYS176)  THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE  |   HISTOCOMPATIBILITY ANTIGEN 
4xxc:A     (GLY1) to   (ASN174)  HLA-B*1801 IN COMPLEX WITH A SELF-PEPTIDE, DELEIKAY  |   EBV, HLA, TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
1duy:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1duy:D     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
3giv:A     (GLY1) to   (GLU161)  ANTIGEN PROCESSING INFLUENCES HIV-SPECIFIC CYTOTOXIC T LYMPHOCYTE IMMUNODOMINANCE  |   HIV, MHC, ESCAPE, ANTIGEN, IMMUNE RECOGNITION, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED', IMMUNE SYSTEM 
2d31:A     (SER2) to   (GLY175)  CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER  |   MHC CLASS I, IMMUNE SYSTEM/CELL CYCLE COMPLEX 
1e27:A     (GLY1) to   (ASN174)  NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1(LPPVVAKEI)  |   IMMUNE SYSTEM, HLA B51, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX 
1e28:A     (TYR7) to   (GLY175)  NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM2(TAFTIPSI)  |   HLA B51, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX 
3gsw:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8A PEPTIDE VARIANT  |   HLA, HUMAN CYTOMEGALOVIRUS, PP65, T CELL RECEPTOR (TCR), IMMUNE RESPONSE, PUBLIC RESPONSE, IMMUNODOMINANCE, RESTRAINED RESPONSE, HOST-VIRUS INTERACTION, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
1ed3:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF RAT MINOR HISTOCOMPATIBILITY ANTIGEN COMPLEX RT1-AA/MTF-E.  |   MAJOR HISTOCOMPATIBILITY COMPLEX, RAT MINOR HISTOCOMPATIBILITY COMPLEX, MHC, IMMUNOLOGY, PEPTIDE ANTIGEN PRESENTATION, CELLULAR IMMUNITY, CELL SURFACE RECEPTOR, T CELL RECEPTOR LIGAND, IMMUNE SYSTEM 
1ed3:D     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF RAT MINOR HISTOCOMPATIBILITY ANTIGEN COMPLEX RT1-AA/MTF-E.  |   MAJOR HISTOCOMPATIBILITY COMPLEX, RAT MINOR HISTOCOMPATIBILITY COMPLEX, MHC, IMMUNOLOGY, PEPTIDE ANTIGEN PRESENTATION, CELLULAR IMMUNITY, CELL SURFACE RECEPTOR, T CELL RECEPTOR LIGAND, IMMUNE SYSTEM 
1eey:A     (PHE8) to   (GLY175)  CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V)  |   MAJOR HISTICOMPATIBILITY COMPLEX, PEPTIDE BINDING, CRYSTALLOGRAPHY, IMMUNE SYSTEM 
1eey:D     (PHE8) to   (GLY175)  CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V)  |   MAJOR HISTICOMPATIBILITY COMPLEX, PEPTIDE BINDING, CRYSTALLOGRAPHY, IMMUNE SYSTEM 
1eez:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TO GP2 PEPTIDE VARIANT(I2L/V5L)  |   MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE BINDING, CRYSTALLOGRAPHY, IMMUNE SYSTEM 
1eez:D     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TO GP2 PEPTIDE VARIANT(I2L/V5L)  |   MAJOR HISTOCOMPATIBILITY COMPLEX, PEPTIDE BINDING, CRYSTALLOGRAPHY, IMMUNE SYSTEM 
1q94:A     (TYR7) to   (LYS176)  STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE  |   IMMUNE SYSTEM 
1q94:D     (GLY1) to   (ASN174)  STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE  |   IMMUNE SYSTEM 
4jfd:A     (TYR7) to   (ASN174)  PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR  |   HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY, IMMUNOGLOBULIN 
4jfe:A     (TYR7) to   (LYS176)  PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR  |   HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY 
4jff:A     (GLY1) to   (ASN174)  PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR  |   HLA, TCR, MELANOMA MOTIF, IMMUNE SYSTEM, HIGH AFFINITY 
1efx:A     (GLY1) to   (GLY162)  STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3  |   MHC, HLA, CLASS I, KIR, NK CELL RECEPTOR, IMMUNOGLOBULIN FOLD, RECEPTOR/MHC COMPLEX, IMMUNE SYSTEM 
4jfq:A     (TYR7) to   (ASN174)  A2 HLA COMPLEX WITH L8A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE  |   IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY 
4jfq:D     (TYR7) to   (ASN174)  A2 HLA COMPLEX WITH L8A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE  |   IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY 
1qew:A     (GLY1) to   (LYS176)  HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATED ANTIGEN 3 (RESIDUES 271-279)  |   COMPLEX (MHC PROTEINTIGEN), HISTOCOMPATIBILITY ANTIGEN 
2rfx:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-B*5701, PRESENTING THE SELF PEPTIDE, LSSPVTKSF  |   ALPHA BETA SANDWICH-IMMUNOLOGLOBULIN LIKE, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
1exu:A     (LEU7) to   (LEU156)  CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR  |   IMMUNOGLOBULIN BINDING PROTEIN, IMMUNE SYSTEM 
1qo3:A     (SER2) to   (LEU160)  COMPLEX BETWEEN NK CELL RECEPTOR LY49A AND ITS MHC CLASS I LIGAND H-2DD  |   RECEPTOR/IMMUNE SYSTEM, COMPLEX (NK RECEPTOR/MHC CLASS I), NK CELL, INHIBITORY RECEPTOR, MHC-I, C-TYPE LECTIN-LIKE, HISTOCOMPATIBILITY, B2M, LY49, LY-49 
4jqv:A     (GLY1) to   (ASN174)  HLA-B*18:01 IN COMPLEX WITH EPSTEIN-BARR VIRUS BZLF1-DERIVED PEPTIDE (RESIDUES 173-180)  |   IMMUNOGLOBULIN FOLD, ANTIGEN PRESENTATION, T-CELL RECEPTOR, EXTRACELLULAR, IMMUNE SYSTEM 
4jqx:A     (TYR7) to   (ASN174)  HLA-B*44:03 IN COMPLEX WITH EPSTEIN-BARR VIRUS BZLF1-DERIVED PEPTIDE (RESIDUES 169-180)  |   IMMUNOGLOBULIN FOLD, ANTIGEN PRESENTATION, T-CELL RECEPTOR, EXTRACELLULAR, IMMUNE SYSTEM 
4jry:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF SB47 TCR-HLA B*3505-LPEP COMPLEX  |   TCR, T CELL, HLA B*3508, LPEP, EBV, ALLOREACTIVITY, IMMUNE SYSTEM 
1qse:A     (TYR7) to   (GLY175)  STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R  |   HUMAN T CELL RECEPTOR, TCR/PEPTIDE/MHC COMPLEX, HLA-A2, IMMUNE SYSTEM 
1qsf:A     (GLY1) to   (ASN174)  STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A  |   HUMAN T CELL RECEPTOR, TCR/PEPTIDE/MHC COMPLEX, HLA-A2, IMMUNE SYSTEM 
1qvo:A     (GLY1) to   (ASN174)  STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE  |   IMMUNE SYSTEM 
1qvo:D     (GLY1) to   (LYS176)  STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE  |   IMMUNE SYSTEM 
3h9h:D     (GLY1) to   (LYS176)  HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TEL1P PEPTIDE  |   TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3h9s:A     (GLY1) to   (ASN174)  THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TEL1P PEPTIDE  |   TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3hae:D     (TYR7) to   (LEU160)  RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES  |   FAB, MAJOR HISTOCOMPATABILITY COMPLEX, IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
2uwe:A     (GLY1) to   (LYS176)  LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION  |   HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM, MHC I, MEMBRANE, RECEPTOR, CLASS I MHC, HYPOTHETICAL PROTEIN, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN, IMMUNE RESPONSE, TCR-PMHC COMPLEX, T CELL SIGNALING, DISEASE MUTATION 
2uwe:H     (GLY1) to   (LYS176)  LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION  |   HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM, MHC I, MEMBRANE, RECEPTOR, CLASS I MHC, HYPOTHETICAL PROTEIN, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN, IMMUNE RESPONSE, TCR-PMHC COMPLEX, T CELL SIGNALING, DISEASE MUTATION 
3hcv:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)  |   IMMUNE SYSTEM/COMPLEX, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX) I, HLA-B*2709, GLYCOPROTEIN, HOST-VIRUS, IMMUNE RESPONSE, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, PYRROLIDONE CARBOXYLIC ACID, SECRETED, DISULFIDE BOND, MHC I 
2v2x:D     (TYR7) to   (LYS176)  T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT.  |   IMMUNE SYSTEM, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE RESPONSE, DISEASE MUTATION, MHC TCR HLA-A2 HIV, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MHC I, MEMBRANE, POLYMORPHISM, GLYCOPROTEIN, PYRROLIDONE CARBOXYLIC ACID 
2esv:A     (SER2) to   (LEU160)  STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX  |   T CELL RECEPTOR, TCR, HLA-E, CMV, PMHC/TCR COMPLEX, IMMUNE SYSTEM 
4k7f:A     (SER2) to   (ASN174)  NEWLY IDENTIFIED EPITOPE V60 FROM HBV CORE PROTEIN COMPLEXED WITH HLA- A*0201  |   HOST-VIRUS INTERACTION, IMMUNE RESPONSE, DISEASE MUTATION, VIRAL REPLICATION, IG-LIKE DOMAIN, IMMUNE SYSTEM, TCR, MEMBRANE GLYCOPROTEIN, VIRAL CAPSID PROTEIN 
4k7f:D     (TYR7) to   (ASN174)  NEWLY IDENTIFIED EPITOPE V60 FROM HBV CORE PROTEIN COMPLEXED WITH HLA- A*0201  |   HOST-VIRUS INTERACTION, IMMUNE RESPONSE, DISEASE MUTATION, VIRAL REPLICATION, IG-LIKE DOMAIN, IMMUNE SYSTEM, TCR, MEMBRANE GLYCOPROTEIN, VIRAL CAPSID PROTEIN 
2f54:A     (GLY1) to   (GLY175)  DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY  |   T-CELL RECEPTOR, CDR2, PHAGE DISPLAY, WILD TYPE SEQUENCE, HIGH AFFINITY, NY-ESO-1, IMMUNE SYSTEM 
3hpj:D     (GLY1) to   (ASN174)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) PEPTIDE  |   WT-1, WT1, WT126 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, CANCER VACCINE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3uts:A     (GLY1) to   (ASN174)  1E6-A*0201-ALWGPDPAAA COMPLEX, MONOCLINIC  |   MAJOR HISTOCOMPATIBILITY COMPLEX, HUMAN LEUKOCYTE ANTIGEN, TYPE I DIABETES, T CELL RECEPTOR, IMMUNE SYSTEM 
3uts:F     (GLY1) to   (GLY175)  1E6-A*0201-ALWGPDPAAA COMPLEX, MONOCLINIC  |   MAJOR HISTOCOMPATIBILITY COMPLEX, HUMAN LEUKOCYTE ANTIGEN, TYPE I DIABETES, T CELL RECEPTOR, IMMUNE SYSTEM 
3utt:F     (GLY1) to   (GLY175)  1E6-A*0201-ALWGPDPAAA COMPLEX, TRICLINIC  |   MAJOR HISTOCOMPATIBILITY COMPLEX, HUMAN LEUKOCYTE ANTIGEN, TYPE I DIABETES, T CELL RECEPTOR, IMMUNE SYSTEM 
1s7x:G     (GLY1) to   (GLY175)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1s8d:A     (GLY1) to   (LYS176)  STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3A  |   CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE- MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM 
4zez:D     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX  |   HCV TCR, HLA-A2, HCV NS3:1406-1415 PEPTIDE, DECAPEPTIDE, PROTEIN BINDING, IMMUNE SYSTEM COMPLEX, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX 
2vlj:A     (GLY1) to   (LYS176)  THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN  |   IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, TCR, FLU, MHC, MHC I, T-CELL, COMPLEX 
2vlk:A     (GLY1) to   (LYS176)  THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN  |   IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, TCR, FLU, MHC, MHC I, T-CELL, COMPLEX 
2vll:A     (GLY1) to   (ASN174)  THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN  |   IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, POLYMORPHISM, TCR, FLU, MHC, MHC I, T-CELL, PEPTIDE, COMPLEX 
2vll:D     (GLY1) to   (LYS176)  THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN  |   IMMUNE SYSTEM, GLYCOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, IMMUNODOMINANCE, DISEASE MUTATION, MEMBRANE, SECRETED, RECEPTOR, GLYCATION, POLYMORPHISM, TCR, FLU, MHC, MHC I, T-CELL, PEPTIDE, COMPLEX 
3v5k:A     (GLY1) to   (ASN174)  HLA2.1 KVAELVWFL  |   PEPTIDE-BINDING GROOVE, T CELL RECEPTOR, IMMUNE SYSTEM 
3v5k:D     (GLY1) to   (ASN174)  HLA2.1 KVAELVWFL  |   PEPTIDE-BINDING GROOVE, T CELL RECEPTOR, IMMUNE SYSTEM 
2fyy:A     (GLY1) to   (GLY175)  THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION  |   MHC, HLA-B*3501, IG DOMAIN, IMMUNE SYSTEM 
2fz3:A     (GLY1) to   (ASN174)  THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION  |   MHC, HLA-B*3508, IG DOMAIN, IMMUNE SYSTEM 
3vcl:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA-B7 WITH THE HCMV PP65 PEPTIDE RPHERNGFTVL  |   CLASS I HISTOCOMPATIBILITY ANTIGEN, ANTIGEN PRESENTATION, T-CELL RECEPTOR, MEMBRANE, IMMUNE SYSTEM 
3i6g:A     (GLY1) to   (LYS176)  NEWLY IDENTIFIED EPITOPE MN2 FROM SARS-COV M PROTEIN COMPLEXED WITHHLA-A*0201  |   HLA-A2, SARS-COV, MEMBRANE GLYCOPROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ENVELOPE PROTEIN, GOLGI APPARATUS, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM 
3i6g:D     (GLY1) to   (LYS176)  NEWLY IDENTIFIED EPITOPE MN2 FROM SARS-COV M PROTEIN COMPLEXED WITHHLA-A*0201  |   HLA-A2, SARS-COV, MEMBRANE GLYCOPROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ENVELOPE PROTEIN, GOLGI APPARATUS, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM 
3i6k:A     (GLY1) to   (LEU160)  NEWLY IDENTIFIED EPITOPE FROM SARS-COV MEMBRANE PROTEIN COMPLEXED WITH HLA-A*0201  |   HLA-A2, SARS-COV, MEMBRANE GLYCOPROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ENVELOPE PROTEIN, GOLGI APPARATUS, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM 
3i6k:E     (GLY1) to   (LEU160)  NEWLY IDENTIFIED EPITOPE FROM SARS-COV MEMBRANE PROTEIN COMPLEXED WITH HLA-A*0201  |   HLA-A2, SARS-COV, MEMBRANE GLYCOPROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ENVELOPE PROTEIN, GOLGI APPARATUS, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM 
3i6l:D     (SER2) to   (LYS176)  NEWLY IDENTIFIED EPITOPE N1 DERIVED FROM SARS-COV N PROTEIN COMPLEXED WITH HLA-A*2402  |   HLA-A*2402, SARS-COV, NUCLEOCAPSID PROTEIN, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, GOLGI APPARATUS, PHOSPHOPROTEIN, RIBONUCLEOPROTEIN, RNA-BINDING, VIRAL NUCLEOPROTEIN, VIRION, IMMUNE SYSTEM 
1sys:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY  |   HLA, MHC, CLASS I, B44, IMMUNE SYSTEM 
1syv:A     (GLY1) to   (GLY175)  HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF  |   HLA, MHC, CLASS I, B44, IMMUNE SYSTEM 
3vfm:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA B*3508 LPEP155A, HLA MUTANT ALA155  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vfn:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA B*3508LPEP151A, HLA MUTANT ALA151  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vfo:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA B*3508 LPEP157A, HLA MUTANT ALA157  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vfp:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA B*3508 LPEP158G, HLA MUTANT GLY158  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vfr:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA B*3508LPEP-P4ALA, PEPTIDE MUTANT P4-ALA  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vft:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA B*3508LPEP-P6ALA, PEPTIDE MUTANT P6-ALA  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vfu:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P7ALA, PEPTIDE MUTANT P7-ALA  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vfv:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P9ALA, PEPTIDE MUTANT P9-ALA  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vfw:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P10ALA, PEPTIDE MUTANT P10-ALA  |   HLA B*3508, EPSTEIN BARR VIRUS, TCR, T CELL, IMMUNE SYSTEM, ANTIGEN- PRESENTING MOLECULE 
3vh8:A     (SER2) to   (GLY175)  KIR3DL1 IN COMPLEX WITH HLA-B*5701  |   IMMUNOGLOBULIN FOLD, NATURAL KILLER CELL RECEPTOR, IMMUNE SYSTEM 
3vh8:D     (GLY1) to   (GLY175)  KIR3DL1 IN COMPLEX WITH HLA-B*5701  |   IMMUNOGLOBULIN FOLD, NATURAL KILLER CELL RECEPTOR, IMMUNE SYSTEM 
1t1w:A     (GLY1) to   (ASN174)  STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3F6I8V  |   CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM 
1t20:A     (GLY1) to   (ASN174)  STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6I  |   CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM 
1t21:A     (GLY1) to   (ASN174)  STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, MONOCLINIC CRYSTAL  |   CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM 
1t22:A     (GLY1) to   (ASN174)  STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, ORTHORHOMBIC CRYSTAL  |   CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM 
2git:D     (TYR7) to   (LYS176)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE MODIFIED HTLV-1 TAX (Y5K- 4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE  |   HTLV-1 TAX PEPTIDE, HAPTENATED PEPTIDE, LYSINE-4-(3-INDOLYL)-BUTYRIC ACID, MHC CLASS I,HLA-A2, IMMUNE SYSTEM 
3vj6:A     (SER1) to   (LEU174)  STRUCTURE OF THE MHC CLASS IB MOLECULE QA-1B  |   MHC-CLASSIB, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, PEPTIDE PRESENTATION, CD94-NKG2A/C RECEPTORS 
4l4t:A     (THR2) to   (TYR171)  STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP  |   MHC CLASS I-RELATED PROTEIN, MAIT TCR, IMMUNE SYSTEM, VITAMIN B METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX 
4l4t:C     (TYR7) to   (GLY172)  STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP  |   MHC CLASS I-RELATED PROTEIN, MAIT TCR, IMMUNE SYSTEM, VITAMIN B METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX 
1t7y:A     (GLY6) to   (GLU163)  ZN-ALPHA-2-GLYCOPROTEIN; BACULO-ZAG PEG 200, NO GLYCEROL  |   MHC CLASS I HOMOLOG, LIPID BINDING PROTEIN 
4lcc:C   (SER117) to   (GLY285)  CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH A BACTERIAL ANTIGEN BOUND TO HUMANIZED BOVINE MR1  |   IMMUNOGLOBULIN DOMAIN, MHC-CLASS I-LIKE, ANTIGEN PRESENTATION, ANTIGEN RECOGNITION, B VITAMINS METABOLITES, CELL MEMBRANE, IMMUNE SYSTEM 
2gtz:A     (GLY1) to   (ASN174)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A28L SUBSTITUTION  |   MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, A28L MUTATION, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM 
2gtz:D     (GLY1) to   (ASN174)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A28L SUBSTITUTION  |   MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, A28L MUTATION, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM 
4lcw:A     (THR2) to   (TYR171)  THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH  |   MHC CLASS I-RELATED PROTEIN, MAIT T CELL RECEPTOR, VITAMIN B2 METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX 
2guo:D     (SER2) to   (ASN174)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NATIVE NONAMERIC MELAN- A/MART-1(27-35) PEPTIDE  |   MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM 
4lcy:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA-B46 AT 1.6 ANGSTROM RESOLUTION  |   ANTIGEN PRESENTING, CELL SURFACE, HLA-B46, MEMBRANE PROTEIN 
4zus:A     (GLY1) to   (ASN176)  CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE REV-QW11  |   LENTIVIRUS VACCINE, IMMUNE SYSTEM 
4zut:A     (GLY1) to   (ASN176)  CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE GAG-GW12  |   LENTIVIRUS VACCINE, IMMUNE SYSTEM 
4zuu:A     (GLY1) to   (ASN176)  CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE GAG-CF9  |   LENTIVIRUS VACCINE, IMMUNE SYSTEM 
4zuv:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE ENV-RW12  |   LENTIVIRUS VACCINE, IMMUNE SYSTEM 
4zuv:D     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE ENV-RW12  |   LENTIVIRUS VACCINE, IMMUNE SYSTEM 
4zuw:A     (GLY1) to   (ASN176)  CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00601) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE GAG-GW12  |   LENTIVIRUS VACCINE, IMMUNE SYSTEM 
1hhh:A     (GLY1) to   (LEU160)  THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2  |   HISTOCOMPATIBILITY ANTIGEN 
1hhi:A     (SER2) to   (GLY162)  THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2  |   HISTOCOMPATIBILITY ANTIGEN 
1hhi:D     (SER2) to   (THR163)  THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2  |   HISTOCOMPATIBILITY ANTIGEN 
1hhj:A     (SER2) to   (LYS176)  THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2  |   HISTOCOMPATIBILITY ANTIGEN 
1hhj:D     (PHE8) to   (LYS176)  THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2  |   HISTOCOMPATIBILITY ANTIGEN 
1hhk:A     (GLY1) to   (LYS176)  THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2  |   HISTOCOMPATIBILITY ANTIGEN 
1hhk:D     (GLY1) to   (LYS176)  THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2  |   HISTOCOMPATIBILITY ANTIGEN 
1tmc:A     (GLY1) to   (GLY175)  THE THREE-DIMENSIONAL STRUCTURE OF A CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE MISSING THE ALPHA3 DOMAIN OF THE HEAVY CHAIN  |   HISTOCOMPATIBILITY ANTIGEN 
3ixa:A     (GLY1) to   (LEU160)  HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TAX PEPTIDE  |   TEL1P, TAX, A150P MUTATION, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3ixa:D     (GLY1) to   (LYS176)  HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TAX PEPTIDE  |   TEL1P, TAX, A150P MUTATION, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
1hsb:A     (GLY1) to   (ASN174)  DIFFERENT LENGTH PEPTIDES BIND TO HLA-AW68 SIMILARLY AT THEIR ENDS BUT BULGE OUT IN THE MIDDLE  |   HISTOCOMPATIBILITY ANTIGEN, IMMUNE SYSTEM 
1tvb:D     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100(209-217) BOUND TO HUMAN CLASS I MHC HLA-A2  |   MELANOMA; X-RAY; GP100; PEPTIDE; MHC; HLA-A2, IMMUNE SYSTEM 
1tvh:D     (SER2) to   (LYS176)  CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2  |   MELANOMA; X-RAY; MODIFIED GP100 PEPTIDE; GP100(209-T2M) PEPTIDE; MHC; HLA-A2, IMMUNE SYSTEM 
3vrj:A     (SER2) to   (GLY175)  HLA-B*57:01-LTTKLTNTNI IN COMPLEX WITH ABACAVIR  |   HUMAN LEUKOCYTE ANTIGEN, ANTIGEN PRESENTATION, IMMUNE SYSTEM, T-CELL RECEPTOR 
2hjk:A     (SER2) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE  |   B57, HLA, HIV, IMMUNE SYSTEM 
2hla:A     (GLY1) to   (TYR159)  SPECIFICITY POCKETS FOR THE SIDE CHAINS OF PEPTIDE ANTIGENS IN HLA-AW68  |   HISTOCOMPATIBILITY ANTIGEN 
4lnr:A     (GLY1) to   (GLY175)  THE STRUCTURE OF HLA-B*35:01 IN COMPLEX WITH THE PEPTIDE (RPQVPLRPMTY)  |   HETEROTRIMER, LIGAND FOR T CELL RECEPTOR, IMMUNE SYSTEM 
1i1y:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y  |   HUMAN CLASS I MHC, HIV, IMMUNE SYSTEM 
3vxn:A     (GLY1) to   (ASN174)  HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(WT)  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, MHC, IMMUNE ESPONSE 
3vxo:A     (GLY1) to   (GLY175)  HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(2F)  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, MHC, IMMUNE ESPONSE 
3vxo:D     (SER2) to   (GLY175)  HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(2F)  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, MHC, IMMUNE ESPONSE 
3vxp:A     (GLY1) to   (GLY175)  HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(6L)  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, MHC, IMMUNE ESPONSE 
3vxp:D     (GLY1) to   (ASN174)  HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(6L)  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, MHC, IMMUNE ESPONSE 
3vxr:A     (GLY1) to   (LEU160)  THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(WT) PEPTIDE  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE 
3vxs:A     (GLY1) to   (LYS176)  THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(6L) PEPTIDE  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE 
3vxu:A     (GLY1) to   (LYS176)  THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE 
3vxu:F     (GLY1) to   (GLY175)  THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE 
3w0w:A     (GLY1) to   (LYS176)  THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE IN SPACE GROUP P212121  |   HIV-1, NEF, HLA-A24, T CELL RECEPTOR, MHC CLASS I, TCR, MHC, IMMUNOGLOBURIN DOMAIN, IMMUNE SYSTEM, IMMUNE RESPONSE 
1i4f:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4-PEPTIDE COMPLEX  |   MAJOR HISTOCOMPATIBILITY COMPLEX, HUMAN LEUKOCYTE ANTIGEN, MELANOMA-ASSOCIATED ANTIGEN, IMMUNE SYSTEM 
3w39:D     (SER3) to   (GLY176)  CRYSTAL STRUCTURE OF HLA-B*5201 IN COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE (TAFTIPSI)  |   CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, MEMBRANE, IMMUNE SYSTEM 
1i7r:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058  |   MHC FOLD, IMMUNE SYSTEM 
1i7r:D     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058  |   MHC FOLD, IMMUNE SYSTEM 
1i7t:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V  |   MHC FOLD, IMMUNE SYSTEM 
1i7t:D     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V  |   MHC FOLD, IMMUNE SYSTEM 
1i7u:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V  |   MHC FOLD, IMMUNE SYSTEM 
1i7u:D     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V  |   MHC FOLD, IMMUNE SYSTEM 
1im3:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX  |   BETA SHEET, BETA SANDWHICH, IMMUNOGLOBULIN (IG) FOLD, IMMUNOGLOBULIN (IG)-LIKE DOMAIN, PROTEIN COMPLEX, ALPHA HELIX, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
1im3:E     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX  |   BETA SHEET, BETA SANDWHICH, IMMUNOGLOBULIN (IG) FOLD, IMMUNOGLOBULIN (IG)-LIKE DOMAIN, PROTEIN COMPLEX, ALPHA HELIX, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
1im3:I     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX  |   BETA SHEET, BETA SANDWHICH, IMMUNOGLOBULIN (IG) FOLD, IMMUNOGLOBULIN (IG)-LIKE DOMAIN, PROTEIN COMPLEX, ALPHA HELIX, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
1im3:M     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX  |   BETA SHEET, BETA SANDWHICH, IMMUNOGLOBULIN (IG) FOLD, IMMUNOGLOBULIN (IG)-LIKE DOMAIN, PROTEIN COMPLEX, ALPHA HELIX, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
1im9:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELL INHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4  |   PROTEIN-PROTEIN COMPLEX, IMMUNOGLOBULIN DOMAIN, ANTIPARALLEL BETA SHEET, ALPHA HELIX, IMMUNE SYSTEM 
1uxs:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS  |   IMMUNE SYSTEM/PEPTIDE, COMPLEX (HLA/PEPTIDE), IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2705, EPSTEIN-BARR VIRUS, 
2x4o:D     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120-128  |   GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, PHOSPHOPROTEIN, IMMUNE RESPONSE, SECRETED, GLYCATION, AMYLOIDOSIS, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, AMYLOID, MEMBRANE, PHOTOCLEAVABLE PEPTIDE, PYRROLIDONE CARBOXYLIC ACID, ENVELOPE PROTEIN, DISEASE MUTATION 
2x4p:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE  |   GLYCOPROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, MATRIX (M1) 
2x4q:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE  |   IMMUNE SYSTEM, AMYLOID, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, HOST-VIRUS INTERACTION, PHOTOCLEAVABLE PEPTIDE 
2x4q:D     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE  |   IMMUNE SYSTEM, AMYLOID, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, HOST-VIRUS INTERACTION, PHOTOCLEAVABLE PEPTIDE 
2x4s:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN  |   PHOTOCLEAVABLE PEPTIDE, GLYCOPROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, MATRIX (M1) 
2x4u:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 PEPTIDE RT468-476  |   GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, PHOSPHOPROTEIN, IMMUNE RESPONSE, SECRETED, GLYCATION, AMYLOIDOSIS, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, AMYLOID, MEMBRANE, PHOTOCLEAVABLE PEPTIDE, PYRROLIDONE CARBOXYLIC ACID, ENVELOPE PROTEIN, DISEASE MUTATION 
2x4u:D     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 PEPTIDE RT468-476  |   GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, PHOSPHOPROTEIN, IMMUNE RESPONSE, SECRETED, GLYCATION, AMYLOIDOSIS, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, AMYLOID, MEMBRANE, PHOTOCLEAVABLE PEPTIDE, PYRROLIDONE CARBOXYLIC ACID, ENVELOPE PROTEIN, DISEASE MUTATION 
2x70:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE  |   IMMUNE SYSTEM, AMYLOID, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, HOST-VIRUS INTERACTION 
3wl9:A     (GLY1) to   (ASN174)  HLA-A24 IN COMPLEX WITH HIV-1 NEF126-10(8I10F)  |   HIV-1, NEF, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM, TCR, T CELL RECEPTOR 
3wlb:A     (GLY1) to   (LYS176)  HLA-A24 IN COMPLEX WITH HIV-1 NEF126-10(8T10F)  |   HIV-1, NEF, HLA-A24, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, IMMUNE RESPONSE, IMMUNE SYSTEM, TCR, T CELL RECEPTOR 
4mj5:A     (GLY1) to   (GLY175)  HLA-A11 COMPLEXED WITH A PEPITDE  |   MHC, T CELL RESPONSES, IMMUNE SYSTEM-PEPTIDE COMPLEX 
4mj6:A     (GLY1) to   (LYS176)  HLA-A11 COMPLEXED WITH A MUTATED PEPTIDE  |   MHC, T CELL RESPONSES, IMMUNE SYSTEM-PEPTIDE COMPLEX 
1jgd:A     (GLY1) to   (GLY175)  HLA-B*2709 BOUND TO DECA-PEPTIDE S10R  |   MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA (HUMAN LEUKOCYTE ANTIGEN), IMMUNE SYSTEM 
1jge:A     (GLY1) to   (GLY175)  HLA-B*2705 BOUND TO NONA-PEPTIDE M9  |   MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA (HUMAN LEUKOCYTE ANTIGEN), IMMUNE SYSTEM 
4mvb:A     (SER4) to   (GLY175)  42F3 PCPB7/H-2LD COMPLEX  |   IG, TCR, MHC, IMMUNE SYSTEM 
2j8u:A     (GLY1) to   (ASN174)  LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.  |   GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, MHC I, MEMBRANE, SECRETED, GLYCATION, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, DISEASE MUTATION, IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL 
2j8u:H     (GLY1) to   (LYS176)  LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.  |   GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, MHC I, MEMBRANE, SECRETED, GLYCATION, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, DISEASE MUTATION, IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL 
4mxq:A     (PRO2) to   (GLY175)  42F3 TCR PCPC5/H-2LD COMPLEX  |   IG, TCR, MHC, IMMUNE SYSTEM, ANTIGEN 
1w0v:A     (SER2) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1  |   IMMUNE SYSTEM, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, HLA- B*2705, MHC I 
1w0w:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1  |   IMMUNE SYSTEM, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, HLA- B*2705, MHC I 
3x11:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA-B*57:01.I80N.L82R.R83G  |   IMMUNOGLOBULIN FOLD, IMMUNITY, ANTIGEN PRESENTATION, IMMUNE RECEPTORS LILRS, TCRS, KIRS, PLASMA MEMBRANE, IMMUNE SYSTEM 
2jcc:A     (GLY1) to   (LYS176)  AH3 RECOGNITION OF MUTANT HLA-A2 W167A  |   GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MHC I, MEMBRANE, RECEPTOR, POLYMORPHISM, PYRROLIDONE CARBOXYLIC ACID, IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL, UBL CONJUGATION, IMMUNE RESPONSE, HYPOTHETICAL PROTEIN 
2jcc:H     (GLY1) to   (LYS176)  AH3 RECOGNITION OF MUTANT HLA-A2 W167A  |   GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MHC I, MEMBRANE, RECEPTOR, POLYMORPHISM, PYRROLIDONE CARBOXYLIC ACID, IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL, UBL CONJUGATION, IMMUNE RESPONSE, HYPOTHETICAL PROTEIN 
5b38:A     (SER2) to   (ASN174)  KIR3DL1*005 IN COMPLEX WITH HLA-B*57:01  |   INNATE IMMUNE RECEPTOR, KIR, NATURAL KILLER CELL, IMMUNE SYSTEM 
5b39:A     (SER2) to   (ASN174)  KIR3DL1*015 IN COMPLEX WITH HLA-B*57:01  |   INNATE IMMUNE RECEPTOR, KIR, NATURAL KILLER CELL, IMMUNE SYSTEM 
4n5e:A     (SER4) to   (GLY175)  42F3 TCR PCPA12/H-2LD COMPLEX  |   IG, TCR, MHC, ANTIGEN, IMMUNE SYSTEM 
4n8v:A     (TYR7) to   (LYS176)  CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR2DS2 IN COMPLEX WITH HLA-A  |   ANTIGEN PRESENTATION, CELL LYSING, KIR BINDING, MEMBRANE, KIR2DS2, ACTIVATING KIR, IMMUNE SYSTEM 
4n8v:D     (TYR7) to   (ASN174)  CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR2DS2 IN COMPLEX WITH HLA-A  |   ANTIGEN PRESENTATION, CELL LYSING, KIR BINDING, MEMBRANE, KIR2DS2, ACTIVATING KIR, IMMUNE SYSTEM 
5brz:A     (GLY1) to   (ASN174)  MAGE-A3 REACTIVE TCR IN COMPLEX WITH MAGE-A3 IN HLA-A1  |   IMMUNO PMHC TCR MAGE, IMMUNE SYSTEM 
5bs0:A     (GLY1) to   (ASN174)  MAGE-A3 REACTIVE TCR IN COMPLEX WITH TITIN EPITOPE IN HLA-A1  |   IMMUNO PMHC TCR TITIN, IMMUNE SYSTEM 
1k5n:A     (SER2) to   (ASN174)  HLA-B*2709 BOUND TO NONA-PEPTIDE M9  |   MHC(MAJOR HISTOCOMPATIBILITY COMPLEX), HLA(HUMAN LEUKOCYTE ANTIGEN), IMMUNE SYSTEM 
1k8d:A     (TYR7) to   (GLY175)  CRYSTAL STRUCTURE OF THE NON-CLASSICAL MHC CLASS IB QA-2 COMPLEXED WITH A SELF PEPTIDE  |   CRYSTAL STRUCTURE, NON-CLASSICAL MHC CLASS I, ANTIGEN PRESENTATION, PREIMPLANTATION EMBRYO DEVOLEPMENT GENE PRODUCT, QA-2, Q9, IMMUNE SYSTEM 
5bxf:C     (LEU7) to   (PHE157)  APO FCRN STRUCTURE AT PH 4.5  |   FCRN, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX 
4nhu:G     (GLY1) to   (GLY162)  THE M33 TCR P3M33L/H-2 LD COMPLEX  |   IG, TCR, MHC, ANTIGEN, IMMUNE SYSTEM 
5c07:A     (TYR7) to   (LYS176)  1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5c08:A     (GLY1) to   (ASN174)  1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5c08:F     (GLY1) to   (ASN174)  1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5c09:A     (GLY1) to   (ASN174)  HLA CLASS I HISTOCOMPATIBILITY ANTIGEN  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5c09:F     (GLY1) to   (ASN174)  HLA CLASS I HISTOCOMPATIBILITY ANTIGEN  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5c0a:A     (TYR7) to   (ASN174)  1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5c0a:F     (TYR7) to   (LYS176)  1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5c0c:A     (TYR7) to   (LYS176)  1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA  |   IMMUNO, HLA-A02, 1E6-TCR, IMMUNE SYSTEM 
5c0c:F     (TYR7) to   (LYS176)  1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA  |   IMMUNO, HLA-A02, 1E6-TCR, IMMUNE SYSTEM 
5c0d:A     (TYR7) to   (ASN174)  HLA-A02 CARRYING AQWGPDPAAA  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5c0e:A     (GLY1) to   (ASN174)  HLA-A02 CARRYING YLGGPDFPTI  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5c0f:A     (GLY1) to   (LYS176)  HLA-A02 CARRYING RQWGPDPAAV  |   IMMUNO, HLA-A02, 1E6-TCR, IMMUNE SYSTEM 
5c0h:A     (GLY1) to   (ASN174)  HLA-A02 CARRYING MVWGPDPLYV  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-RTEACTIVITY, IMMUNE SYSTEM 
5c0i:A     (TYR7) to   (LYS176)  HAL-A02 CARRYING RQFGPDFPTI  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5c0j:A     (GLY1) to   (LYS176)  HLA-A02 CARRYING RQFGPDWIVA  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
4nnx:A     (SER2) to   (ASN174)  CRYSTAL STRUCTURE OF PKD2 PHOSPHOPEPTIDE BOUND TO HLA-A2  |   PHOSPHOSERINE, PHOSPHOPEPTIDE, MHC, POST TRANSLATIONAL MODIFICATION, TUMOR IMMUNOLOGY, TUMOR ANTIGENS, NEOEPITOPE, IMMUNE SYSTEM-ANTIGEN COMPLEX 
4no0:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF RQA_V PHOSPHOPEPTIDE BOUND TO HLA-A2 IN COMPLEX WITH LILRB1  |   NONPHOSPHORYLATED PEPTIDE, PEPTIDE-MHC COMPLEX, MHC, LILRB1, POST TRANSLATIONAL MODIFICATION, PEPTIDE CONFORMATION, TUMOR IMMUNOLOGY, TUMOR ANTIGEN, NEOEPITOPE, IMMUNE SYSTEM-ANTIGEN COMPLEX 
4no5:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF AMPD2 PHOSPHOPEPTIDE BOUND TO HLA-A2  |   NONPHOSPHORYLATED PEPTIDE, PEPTIDE-MHC COMPLEX, MHC, PEPTIDE CONFORMATION, TUMOR IMMUNOLOGY, POST TRANSLATIONAL MODIFICATION, TUMOR ANTIGENS, IMMUNE SYSTEM-ANTIGEN COMPLEX 
4nqc:A     (TYR7) to   (GLY172)  CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL  |   MR1, T-CELL RECEPTOR, IMMUNE RECEPTOR COMPLEX, IG-FOLD, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM 
4nqc:C     (TYR7) to   (GLY172)  CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL  |   MR1, T-CELL RECEPTOR, IMMUNE RECEPTOR COMPLEX, IG-FOLD, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM 
4nqe:A     (ARG1) to   (TYR171)  CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL  |   IMMUNE COMPLEX, MR1, TCR, IG-DOMAIN, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM 
4nqe:C     (TYR7) to   (GLY172)  CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL  |   IMMUNE COMPLEX, MR1, TCR, IG-DOMAIN, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM 
4nqv:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44, AN 9-MER INFLUENZA EPITOPE  |   IMMUNE SYSTEM, HLA PRESENTING H7N9 VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4nqv:C     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44, AN 9-MER INFLUENZA EPITOPE  |   IMMUNE SYSTEM, HLA PRESENTING H7N9 VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4nqv:E     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44, AN 9-MER INFLUENZA EPITOPE  |   IMMUNE SYSTEM, HLA PRESENTING H7N9 VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4nqv:G     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44, AN 9-MER INFLUENZA EPITOPE  |   IMMUNE SYSTEM, HLA PRESENTING H7N9 VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4nqv:I     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44, AN 9-MER INFLUENZA EPITOPE  |   IMMUNE SYSTEM, HLA PRESENTING H7N9 VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4nqv:K     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44, AN 9-MER INFLUENZA EPITOPE  |   IMMUNE SYSTEM, HLA PRESENTING H7N9 VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4nqx:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N, AN 9-MER INFLUENZA EPITOPE  |   IMMUNE SYSTEM, PRESENTING VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4nqx:C     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N, AN 9-MER INFLUENZA EPITOPE  |   IMMUNE SYSTEM, PRESENTING VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4nqx:E     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N, AN 9-MER INFLUENZA EPITOPE  |   IMMUNE SYSTEM, PRESENTING VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4nqx:G     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N, AN 9-MER INFLUENZA EPITOPE  |   IMMUNE SYSTEM, PRESENTING VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4nqx:I     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N, AN 9-MER INFLUENZA EPITOPE  |   IMMUNE SYSTEM, PRESENTING VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4nqx:K     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N, AN 9-MER INFLUENZA EPITOPE  |   IMMUNE SYSTEM, PRESENTING VIRAL EPITOPE, T CELL RECEPTOR, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4nt6:A     (MET1) to   (LEU160)  HLA-C*0801 CRYSTAL STRUCTURE  |   CLASS I HISTOCOMPATIBILITY ANTIGEN, HLA-C1, HLA-C*08, EXTRACELLULAR, IMMUNE SYSTEM 
2mha:A     (LEU5) to   (ASN174)  CRYSTAL STRUCTURE OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I H-2KB MOLECULE CONTAINING A SINGLE VIRAL PEPTIDE: IMPLICATIONS FOR PEPTIDE BINDING AND T-CELL RECEPTOR RECOGNITION  |   HISTOCOMPATIBILITY ANTIGEN 
1x7q:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSID PEPTIDE  |   PEPTIDE-MHC-COMPLEX, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I, HUMAN LEUKOCYTE ANTIGEN, HLA, IMMUNOGLOBULIN FAMILY, SARS, IMMUNE SYSTEM 
4o2c:A     (GLY1) to   (ASN174)  AN NT-ACETYLATED PEPTIDE COMPLEXED WITH HLA-B*3901  |   IG-LIKE, IMMUNE SYSTEM 
4o2e:A     (GLY1) to   (LYS176)  A PEPTIDE COMPLEXED WITH HLA-B*3901  |   IG-LIKE, IMMUNE SYSTEM 
4o2e:D     (GLY1) to   (ASN174)  A PEPTIDE COMPLEXED WITH HLA-B*3901  |   IG-LIKE, IMMUNE SYSTEM 
4o2f:D     (GLY1) to   (ASN174)  A PEPTIDE COMPLEXED WITH HLA-B*3901  |   IG-LIKE, IMMUNE SYSTEM 
2ypk:A     (SER2) to   (GLY175)  STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS  |   IMMUNE SYSTEM, MICROPOLYMORPHISM 
2ypl:A     (SER2) to   (LEU160)  STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS  |   IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, MICROPOLYMORPHISM 
2nw3:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A  |   MHC, HLA-B*3508, IMMUNE SYSTEM 
2nx5:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A  |   TCR-PMHC, IMMUNE COMPLEX, IMMUNE SYSTEM 
2nx5:F     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A  |   TCR-PMHC, IMMUNE COMPLEX, IMMUNE SYSTEM 
2nx5:K     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A  |   TCR-PMHC, IMMUNE COMPLEX, IMMUNE SYSTEM 
1lp9:A     (GLY1) to   (ASN174)  XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1  |   IMMUNOREGULATORY COMPLEX, CLASS I MHC:TCR CO-CRYSTAL, IMMUNE SYSTEM 
1lp9:H     (GLY1) to   (LYS176)  XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1  |   IMMUNOREGULATORY COMPLEX, CLASS I MHC:TCR CO-CRYSTAL, IMMUNE SYSTEM 
1xr8:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3  |   MAJOR HISTOCOMPATIBILITY ANTIGEN, MHC, HLA, HLA-B62, HLA-B*1501, COMPLEX (ANTIGEN-PEPTIDE), IMMUNE SYSTEM 
1xr9:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3  |   MAJOR HISTOCOMPATIBILITY ANTIGEN, MHC, HLA, HLA-B62, HLA-B*1501, COMPLEX (ANTIGEN-PEPTIDE), IMMUNE SYSTEM-LIGASE COMPLEX 
1m6o:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLA DPA*0201 PEPTIDE  |   MHC I, GLYCOPROTEIN, SIGNAL, IMMUNE SYSTEM 
3kla:A     (GLY1) to   (LYS176)  CA2+ RELEASE FROM THE ENDOPLASMIC RETICULUM OF NY-ESO-1 SPECIFIC T CELLS IS MODULATED BY THE AFFINITY OF T CELL RECEPTOR AND BY THE USE OF THE CD8 CO-RECEPTOR  |   MHC, TUMOUR, IMMUNOLOGY, DISULFIDE BOND, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3kla:D     (GLY1) to   (LYS176)  CA2+ RELEASE FROM THE ENDOPLASMIC RETICULUM OF NY-ESO-1 SPECIFIC T CELLS IS MODULATED BY THE AFFINITY OF T CELL RECEPTOR AND BY THE USE OF THE CD8 CO-RECEPTOR  |   MHC, TUMOUR, IMMUNOLOGY, DISULFIDE BOND, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
5d2n:H     (SER2) to   (ASN174)  CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX  |   TCR, NLV, HLA-A2, IMMUNE SYSTEM 
5d2n:A     (SER2) to   (GLY175)  CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX  |   TCR, NLV, HLA-A2, IMMUNE SYSTEM 
3kpm:A     (SER2) to   (GLY175)  CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE  |   HLA B*4402, ALLORECOGNITION, TCR RECOGNITION, MIMOTOPE PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM 
3kpn:A     (SER2) to   (ASN174)  CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN  |   HLA B*4403, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, IMMUNE SYSTEM 
3kpo:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE  |   HLA B*4403, ALLORECOGNITION, TCR RECOGNITION, MIMOTOPE PEPTIDE, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, IMMUNE SYSTEM 
3kpq:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE  |   HLA B*4405, ALLORECOGNITION, TCR RECOGNITION, MIMOTOPE PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM-PEPTIDE COMPLEX 
3kpr:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE  |   HLA B*4405, TCRPMHC STRUCTURE, TERNARY COMPLEX, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, IMMUNE SYSTEM 
3kps:A     (TYR7) to   (ASN174)  CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN  |   HLA B*4405, TCRPMHC STRUCTURE, TERNARY COMPLEX, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, IMMUNE SYSTEM 
5d5m:A     (ARG1) to   (GLY172)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR  |   ANTIGEN, IMMUNE SYSTEM 
5d5m:C     (ARG1) to   (GLY172)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR  |   ANTIGEN, IMMUNE SYSTEM 
5d7i:C     (TYR7) to   (GLY172)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR  |   ANTIGEN, RECEPTOR, IMMUNE SYSTEM 
5d7j:C     (ARG1) to   (GLY172)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64(Y95ALPHAF) TCR  |   RECEPTOR, ANTIGEN, IMMUNE SYSTEM 
5d9s:A     (GLY1) to   (LYS176)  STRUCTURE OF HLA-A2:01 WITH THE 11-MER PEPTIDE F11V  |   PEPTIDE COMPLEX, MHC, IMMUNE SYSTEM 
3kww:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF THE 'RESTRICTION TRIAD' MUTANT OF HLA B*3508, BETA-2-MICROGLOBULIN AND EBV PEPTIDE  |   MHC-PEPTIDE, HLA, DISULFIDE BOND, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3kyn:A     (MET1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-G PRESENTING KGPPAALTL PEPTIDE  |   HUMAN LEUKOCYTE ANTIGEN, MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNE RESPONSE, MHC I, IMMUNE SYSTEM 
3kyo:A     (SER2) to   (LYS176)  CRYSTAL STRUCTURE OF HLA-G PRESENTING KLPAQFYIL PEPTIDE  |   HUMAN LEUKOCYTE ANTIGEN, MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNE RESPONSE, MHC I, IMMUNE SYSTEM 
3kyo:C     (SER2) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-G PRESENTING KLPAQFYIL PEPTIDE  |   HUMAN LEUKOCYTE ANTIGEN, MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNE RESPONSE, MHC I, IMMUNE SYSTEM 
5ddh:A     (GLY1) to   (LYS176)  STRUCTURE OF HLA-A2:01 WITH THE 12-MER PEPTIDE F12K  |   MHC, IMMUNE SYSTEM, PEPTIDE-PROTEIN COMPLEX 
1n2r:A     (GLY1) to   (ASN174)  A NATURAL SELECTED DIMORPHISM IN HLA B*44 ALTERS SELF, PEPTIDE REPORTOIRE AND T CELL RECOGNITION.  |   MHC I, SIGNAL, IMMUNE SYSTEM 
5deg:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF B*27:06 BOUND TO THE PVIPR PEPTIDE  |   IMMUNE SYSTEM-COMPLEX, IMMUNE SYSTEM, MHC MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2706 
3l3d:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201  |   IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM 
3l3g:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201  |   IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM 
3l3i:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F7A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201  |   IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM 
3l3j:A     (SER2) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A/R5A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201  |   IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM 
3l3k:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A/F7A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201  |   IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, ALTERED PEPTIDE LIGAND, IMMUNE SYSTEM 
4pj7:A     (TYR7) to   (GLY172)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR  |   MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM 
4pj7:C     (TYR7) to   (GLY172)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR  |   MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM 
4pj8:A     (ARG1) to   (GLY172)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV20 TCR  |   MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM 
4pjc:C     (ARG1) to   (GLY172)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-A11 TCR  |   MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM 
4pjh:A     (TYR7) to   (GLU158)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-G8 TCR  |   MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM 
4pjh:C     (TYR7) to   (GLU158)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-G8 TCR  |   MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM 
4pr5:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-D5  |   HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, STRUCTURAL BIOLOGY, IMMUNE SYSTEM 
4pra:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-Q5  |   HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM 
4pre:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-Q5  |   HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM 
4pri:A     (SER2) to   (GLY175)  CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG COMPLEX  |   HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM 
4prn:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-A4  |   HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM 
3am8:A     (GLY1) to   (TYR159)  CRYSTAL STRUCTURE OF A HUMAN MAJOR HISTOCOMPATIBILTY COMPLEX  |   HUMAN LEUKOCYTE ANTIGEN E, MAJOR HISTOCOMPATIBILITY COMPLEX, IMMUNE SYSTEM 
4pv8:A     (GLY1) to   (GLU161)  CRYSTAL STRUCTURE OF H2KB-Q600F COMPLEX  |   TCR, T CELL, H2KB, HETEROCLITIC EPITOPES, CD8 T CELL, CORONAVIRUS, IMMUNE SYSTEM 
1zag:B     (GLY6) to   (SER177)  HUMAN ZINC-ALPHA-2-GLYCOPROTEIN  |   LIPID MOBILIZATION FACTOR, SECRETED MHC CLASS I HOMOLOG 
3lkn:A     (SER2) to   (LYS176)  CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1918 STRAIN  |   HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3lko:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1934 STRAIN  |   HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3lkp:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1972 STRAIN  |   HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
1zhl:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY  |   T-CELL RECEPTOR, BULGED EPITOPES, IMMUNE SYSTEM 
3lkr:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 2009 H1N1 SWINE ORIGIN STRAIN  |   HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3ln4:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-B*4103 IN COMPLEX WITH A 16MER SELF-PEPTIDE DERIVED FROM HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS C1/C2  |   IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I PEPTIDE COMPLEX, PEPTIDE-BINDING MOTIFS, DISULFIDE BOND, IMMUNE SYSTEM 
1zsd:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBV ANTIGEN EPLPQGQLTAY  |   HUMAN LEUKOCYTE ANTIGEN, MAJOR HISTOCOMPATIBILITY COMPLEX I, B35, B*3501, BULGED PEPTIDE, IMMUNE SYSTEM 
1zt1:A     (GLY1) to   (LEU174)  CRYSTAL STRUCTURE OF CLASS I MHC H-2KK IN COMPLEX WITH AN OCTAPEPTIDE  |   PEPTIDE BINDING GROOVE, IMMUNE SYSTEM 
1zvs:D     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF THE FIRST CLASS MHC MAMU AND TAT-TL8 COMPLEX  |   THE FIRST CLASS MHC, MAMU, TAT-TL8, IMMUNE SYSTEM 
3lv3:A     (TYR7) to   (GLY175)  CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH A PEPTIDE DERIVED FROM THE HUMAN VOLTAGE-DEPENDENT CALCIUM CHANNEL ALPHA1 SUBUNIT (RESIDUES 513-521)  |   IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA-B*2705, DISULFIDE BOND, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, SECRETED, CALCIUM CHANNEL, VOLTAGE-GATED CHANNEL 
5e6i:R     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2  |   IMMUNE SYSTEM, TCR, HLA-A2, FLU, COMPLEX 
5e8n:A     (GLY1) to   (GLU161)  THE STRUCTURE OF THE TEIPP ASSOCIATED TRH4 PEPTIDE IN COMPLEX WITH H- 2D(B)  |   CANCER, NEO-EPITOPE, TAP-DEFICIENCY, TEIPP, MHC-I, SULFUR-PI INTERACTIONS, NON-CLASSICAL PEPTIDE BINDING, IMMUNE SYSTEM 
5e9d:A     (GLY1) to   (ASN174)  RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2  |   SINGLE CHAIN TCR-PMHC COMPLEX, PROTEIN BINDING 
5e9d:F     (TYR7) to   (LYS176)  RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2  |   SINGLE CHAIN TCR-PMHC COMPLEX, PROTEIN BINDING 
3m17:A     (LEU7) to   (ARG171)  CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR  |   IMMUNOGLOBULIN BINDING PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, IGG-BINDING PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, RECEPTOR, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNE RESPONSE, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM-INHIBITOR COMPLEX 
3m17:C     (LEU7) to   (ARG171)  CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR  |   IMMUNOGLOBULIN BINDING PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, IGG-BINDING PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, RECEPTOR, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNE RESPONSE, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM-INHIBITOR COMPLEX 
3m17:G     (LEU7) to   (PHE157)  CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR  |   IMMUNOGLOBULIN BINDING PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, IGG-BINDING PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, RECEPTOR, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNE RESPONSE, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM-INHIBITOR COMPLEX 
3m1b:E     (LEU7) to   (ARG171)  CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR  |   IMMUNOGLOBULIN BINDING PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, IGG-BINDING PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, RECEPTOR, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNE RESPONSE, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM-IMMUNE SYSTEM INHIBITOR, IMMUNE SYSTEM- INHIBITOR COMPLEX 
3m1b:G     (LEU7) to   (PHE157)  CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR  |   IMMUNOGLOBULIN BINDING PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, IGG-BINDING PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, RECEPTOR, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNE RESPONSE, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM-IMMUNE SYSTEM INHIBITOR, IMMUNE SYSTEM- INHIBITOR COMPLEX 
2a83:A     (SER2) to   (GLY175)  CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420)  |   IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX),HLA-B*2705 
3b3i:A     (GLY1) to   (ASN174)  CITRULLINATION-DEPENDENT DIFFERENTIAL PRESENTATION OF A SELF-PEPTIDE BY HLA-B27 SUBTYPES  |   HLA-B2709, ANKYLOSING SPONDYLITIS, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, G-PROTEIN COUPLED RECEPTOR, PHOSPHORYLATION, RECEPTOR, TRANSDUCER, PROTEIN BINDING, IMMUNE SYSTEM 
3b6s:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)  |   IMMUNE SISTEM/COMPLEX, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA-B*2705, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
4qok:A     (TYR7) to   (ASN174)  STRUCTURAL BASIS FOR INEFFECTIVE T-CELL RESPONSES TO MHC ANCHOR RESIDUE IMPROVED HETEROCLITIC PEPTIDES  |   IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM 
3mgo:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201  |   BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM 
3mgo:D     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201  |   BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM 
3mgo:G     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201  |   BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM 
3mgo:J     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201  |   BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM 
3mgt:D     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201  |   BETA STRANDS-ALPHA HELIX, IG-LIKE DOMAIN, IMMUNE SYSTEM 
5enw:A     (GLY1) to   (LYS176)  STRUCTURE OF HLA-A2:01 WITH PEPTIDE G9L  |   PEPTIDE COMPLEX, MHC, IMMUNE SYSTEM 
5eo0:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-B0702-RFL9  |   TCR, T CELL, HLA B*0702, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM 
5eo1:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA-B0702-RL9  |   TCR, T CELL, HLA B*0702, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM 
4qrt:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELN_YYM, ELNRKMIYM  |   HLA B*0801, CMV, TCR, T CELL, IMMUNE SYSTEM 
5eu3:A     (GLY1) to   (ASN174)  HLA CLASS I ANTIGEN  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5eu4:A     (GLY1) to   (ASN174)  HLA CLASS I ANTIGEN  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5eu4:D     (GLY1) to   (ASN174)  HLA CLASS I ANTIGEN  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5euo:A     (TYR7) to   (LYS176)  PF6-M1-HLA-A2  |   TCR, FLU, MHC, IMMUNE SYSTEM 
3mrd:A     (SER2) to   (ASN174)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6G VARIANT  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, CYTOMEGALOVIRUS, PP65 PROTEIN 
3mrf:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE T4P VARIANT  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, EPSTEIN-BARR VIRUS, BMLF1 PROTEIN, EB2 PROTEIN 
3mrg:A     (TYR7) to   (ASN174)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN 
3mri:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE G4M-V5W VARIANT  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN 
3mrj:A     (TYR7) to   (ASN174)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE V5M VARIANT  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN 
3mrl:A     (TYR7) to   (ASN174)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE C6V VARIANT  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, NONAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN 
3mrm:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1406-1415 DECAPEPTIDE  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, DECAPEPTIDE, VIRAL PEPTIDE, HEPATITIS C VIRUS, NS3 PROTEIN 
3mrp:A     (TYR7) to   (ASN174)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN- A MART1 DECAPEPTIDE VARIANT  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, DECAPEPTIDE, TUMORAL PEPTIDE, MELAN-A, MART1 
3mrq:A     (SER2) to   (ASN174)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN- A MART1 DECAPEPTIDE VARIANT  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, DECAPEPTIDE, TUMORAL PEPTIDE, MELAN-A, MART1 
3mrr:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HUMAN PROSTAGLANDIN TRANSPORTER DECAPEPTIDE  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, DECAPEPTIDE, PROSTAGLANDIN TRANSPORTER, TUMORAL PEPTIDE, MELAN-A ANALOGUE, MART1 ANALOGUE, SELF PEPTIDE 
3bo8:A     (SER2) to   (LYS176)  THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-A1 COMPLEXED WITH THE MAGE-A1 PEPTIDE  |   MELANOMA ASSOCIATED ANTIGEN, MAGE, MAGE-A1, MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, HLA-A1, HLA-A010101, TCR, T-CELL RECEPTOR, ANTIBODY, FAB-HYB3, HYB3, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MEMBRANE, MHC I, SULFATION, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, PYRROLIDONE CARBOXYLIC ACID, SECRETED, TUMOR ANTIGEN, IMMUNE SYSTEM 
3bp4:A     (GLY1) to   (ASN174)  THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2705 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE PCATA  |   MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, BETA-2-MICROGLOBULIN, B2M, CATHEPSIN A, PCATA, ANKYLOSING SPONDYLITIS, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CARBOXYPEPTIDASE, HYDROLASE, LYSOSOME, PROTEASE, ZYMOGEN, IMMUNE SYSTEM 
3bp7:A     (SER2) to   (ASN174)  THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2709 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE, PCATA  |   MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, HLA-B*2709, HLA-B2709, BETA-2-MICROGLOBULIN, B2M, CATHEPSIN A SIGNAL SEQUENCE, PCATA, ANKYLOSING SPONDYLITIS, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CARBOXYPEPTIDASE, HYDROLASE, LYSOSOME, PROTEASE, ZYMOGEN, IMMUNE SYSTEM 
5f1i:G     (GLY1) to   (LYS177)  MHC WITH 9-MER PEPTIDE  |   MHC, IMMUNE SYSTEM 
5f1i:J     (SER4) to   (TRP157)  MHC WITH 9-MER PEPTIDE  |   MHC, IMMUNE SYSTEM 
5f1i:P     (GLY1) to   (GLY176)  MHC WITH 9-MER PEPTIDE  |   MHC, IMMUNE SYSTEM 
3mv7:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF THE TK3 TCR IN COMPLEX WITH HLA-B*3501/HPVG  |   HLA B*3501, EBV, TCR, TCRPMHC COMPLEX, HPVG, TCR POLYMORPHISM, IMMUNE SYSTEM 
3mv9:A     (SER2) to   (ASN174)  CRYSTAL STRUCTURE OF THE TK3-GLN55ALA TCR IN COMPLEX WITH HLA- B*3501/HPVG  |   HLA B*3501, EBV, TCR, TCRPMHC COMPLEX, HPVG, TCR POLYMORPHISM, IMMUNE SYSTEM 
3bvn:A     (GLY1) to   (GLY175)  HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 IN COMPLEX WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS  |   MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, HLA-B14, HLA-B*14, HLA-B1402, HLA-B*1402, PLMP2, ANKYLOSING SPONDYLITIS, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ALTERNATIVE SPLICING, CYTOPLASM, HOST-VIRUS INTERACTION, MEMBRANE, PHOSPHOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE SYSTEM 
3bvn:D     (GLY1) to   (ASN174)  HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 IN COMPLEX WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS  |   MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEUKOCYTE ANTIGEN, HLA, HLA-B14, HLA-B*14, HLA-B1402, HLA-B*1402, PLMP2, ANKYLOSING SPONDYLITIS, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ALTERNATIVE SPLICING, CYTOPLASM, HOST-VIRUS INTERACTION, MEMBRANE, PHOSPHOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION, IMMUNE SYSTEM 
3bw9:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 12- MER PEPTIDE FROM THE PP65 PROTEIN  |   HLA B*3508, CRYSTAL STRUCTURE, HCMV, PP65, IMMUNOLOGY, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, PHOSPHOPROTEIN, TEGUMENT PROTEIN, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM 
3bxn:A     (GLY1) to   (ASN174)  THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 COMPLEXED WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE, PCATA  |   MAJOR HISTOCOMPATIBILITY COMPLEX, MHC, HUMAN LEOKOCYTE ANTIGEN, HLA, HLA-B14, HLA-B*1402, HLA-B1402, HLA-B*14, PCATA, CATHEPSIN A, ANKYLOSING SPONDYLITIS, AUTOIMMUNITY, IMMUNE SYSTEM 
3c9n:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF A SARS CORONA VIRUS DERIVED PEPTIDE BOUND TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULE HLA-B*1501  |   MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I, MHC-I, HLA-B*1501, SARS, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3nfn:A     (GLY1) to   (LYS176)  RECOGNITION OF PEPTIDE-MHC BY A V-DELTA/V-BETA TCR  |   IMMUNOGLOBULIN FAMILY, IMMUNE SYSTEM 
3czf:A     (SER2) to   (GLY175)  CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420)  |   IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX, HLA- B*2709 
3d18:A     (SER2) to   (GLY175)  CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH A VARIANT OF THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2(L)) OF EPSTEIN-BARR VIRUS  |   IMMUNE SYSTEM-COMPLEX, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, PHOSPHOPROTEIN, IMMUNE SYSTEM 
3d25:A     (TYR7) to   (LYS176)  CRYSTAL STRUCTURE OF HA-1 MINOR HISTOCOMPATIBILITY ANTIGEN BOUND TO HUMAN CLASS I MHC HLA-A2  |   MHC, HLA-A2, SECONDARY ANCHOR RESIDUE, GLYCOPROTEIN, IMMUNE SYSTEM, MINOR HISTOCOMPATIBILITY ANTIGEN, STEM CELL TRANSPLANTATION, IMMUNE RESPONSE 
3d3v:A     (GLY1) to   (LYS176)  THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(3,4-DIFLUOROPHENYLALANINE)) PEPTIDE  |   HTLV-1 TAX PEPTIDE, 3, 4-DIFLUOROPHENYLALANINE, MHC CLASS I, HLA-A2, T-CELL RECEPTOR A6, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, DISEASE MUTATION, GLYCATION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE SYSTEM 
4u1h:A     (GLY1) to   (ASN174)  HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES  |   IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM 
4u1i:A     (GLY1) to   (ASN174)  HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES  |   IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM 
4u1j:A     (GLY1) to   (ASN174)  HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES  |   IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM 
4u1l:A     (GLY1) to   (GLY175)  HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES  |   IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM 
4u1l:D     (SER2) to   (GLY175)  HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES  |   IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM 
4u1m:A     (GLY1) to   (ASN174)  HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES  |   IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM 
4u1n:A     (GLY1) to   (ASN174)  HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES  |   IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM 
4u1s:A     (GLY1) to   (LYS176)  HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES  |   IMMUNOGLOBULIN, HLA, HIV, IMMUNE SYSTEM 
5h94:A     (GLY2) to   (MET175)  CRYSTAL STRUCTURE OF SWINE MHC CLASSI FOR 1.48 ANGSTROMS  |   SWINE; CRYSTAL STRUCTURE; MHC I; INFLUENZA A VIRUS; MECHANISM; CTL IMMUNITY, IMMUNE SYSTEM 
5h94:D     (GLY2) to   (MET175)  CRYSTAL STRUCTURE OF SWINE MHC CLASSI FOR 1.48 ANGSTROMS  |   SWINE; CRYSTAL STRUCTURE; MHC I; INFLUENZA A VIRUS; MECHANISM; CTL IMMUNITY, IMMUNE SYSTEM 
3dtx:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)  |   IMMUNE SYSTEM-COMPLEX, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX) I, HLA- B*2705, GLYCOPROTEIN, HOST-VIRUS, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, SECRETED, MHC I, PYRROLIDONE CARBOXYLIC ACID, IMMUNE SYSTEM 
3dx6:A     (TYR7) to   (ASN174)  CRYSTAL STRUCTURE OF B*4402 PRESENTING A 10MER EBV EPITOPE  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
3dx8:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF B*4405 PRESENTING A 10MER EBV EPITOPE  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
3dxa:A     (SER2) to   (GLY175)  CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
3dxa:F     (SER2) to   (GLY175)  CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
3dxa:K     (SER2) to   (GLY175)  CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
3ox8:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA A*02:03 BOUND TO HBV CORE 18-27  |   PROTEIN-PEPTIDE COMPLEX, HOST-VIRUS INTERACTION, IMMUNOGENICITY, THERAPEUTIC DESIGN, TCR RECOGNITION, HELIX, BETA-SHEET, ANTIGEN PRESENTATION, PEPTIDE BINDING, CELL SURFACE, IMMUNE SYSTEM 
3ox8:D     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA A*02:03 BOUND TO HBV CORE 18-27  |   PROTEIN-PEPTIDE COMPLEX, HOST-VIRUS INTERACTION, IMMUNOGENICITY, THERAPEUTIC DESIGN, TCR RECOGNITION, HELIX, BETA-SHEET, ANTIGEN PRESENTATION, PEPTIDE BINDING, CELL SURFACE, IMMUNE SYSTEM 
3oxr:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA A*02:06 BOUND TO HBV CORE 18-27  |   PROTEIN-PEPTIDE COMPLEX, HOST-VIRUS INTERACTION, IMMUNOGENICITY, THERAPEUTIC DESIGN, TCR RECOGNITION, HELIX, BETA-SHEET, ANTIGEN PRESENTATION, PEPTIDE BINDING, CELL SURFACE, IMMUNE SYSTEM 
3oxs:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA A*02:07 BOUND TO HBV CORE 18-27  |   PROTEIN-PEPTIDE COMPLEX, HOST-VIRUS INTERACTION, IMMUNOGENICITY, THERAPEUTIC DESIGN, TCR RECOGNITION, HELIX, BETA-SHEET, ANTIGEN PRESENTATION, PEPTIDE BINDING, CELL SURFACE, IMMUNE SYSTEM 
5hga:A     (GLY1) to   (LYS176)  HLA*A2402 COMPLEX WITH HIV NEF138 Y2F-8MER MUTANT EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hga:D     (GLY1) to   (ASN174)  HLA*A2402 COMPLEX WITH HIV NEF138 Y2F-8MER MUTANT EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hgb:A     (GLY1) to   (ASN174)  HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hgb:G     (GLY1) to   (LYS176)  HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hgb:J     (GLY1) to   (LYS176)  HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hgd:A     (SER2) to   (ASN174)  HLA*A2402 COMPLEXED WITH HIV NEF138 Y2F MUTANT 10MER EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hgd:D     (SER2) to   (ASN174)  HLA*A2402 COMPLEXED WITH HIV NEF138 Y2F MUTANT 10MER EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hgh:A     (GLY1) to   (LYS176)  HLA*A2402 COMPLEXED WITH HIV NEF138 10MER EPITOPE  |   HLA, ANTIGEN PRESENTATION, HIV, IMMUNE SYSTEM 
5hhn:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-F5L  |   HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM 
5hho:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-G4E  |   HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM 
5hhq:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-L3W  |   HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM 
4u6x:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH ALQDA, A 15 MER SELF- PEPTIDE  |   HLA A*0201, LIGANDOME, TCR, T CELL, IMMUNE SYSTEM 
3p73:A     (PHE0) to   (HIS171)  CRYSTAL STRUCTURES OF THE CHICKEN YF1*7.1 MOLECULE  |   IG-LIKE C1-TYPE (IMMUNOGLOBULIN-LIKE) DOMAIN, HISTOCOMPATIBILITY ANTIGEN, IMMUNE SYSTEM 
3p77:A     (PHE0) to   (THR159)  CRYSTAL STRUCTURES OF THE CHICKEN YF1*7.1 MOLECULE  |   IG-LIKE C1-TYPE (IMMUNOGLOBULIN-LIKE) DOMAIN, HISTOCOMPATIBILITY ANTIGEN, IMMUNE SYSTEM 
5hyj:A     (GLY1) to   (LYS176)  1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5hyj:F     (GLY1) to   (THR163)  1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
4uq2:A     (GLY1) to   (LEU160)  CRYSTAL STRUCTURE OF HLA-A1101 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE  |   AZOBENZENE, HLA-A, SYNTHETIC PEPTIDE, IMMUNE SYSTEM 
4uq2:C     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-A1101 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE  |   AZOBENZENE, HLA-A, SYNTHETIC PEPTIDE, IMMUNE SYSTEM 
4uq3:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA-A0201 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE  |   IMMUNE SYSTEM, AZOBENZENE, HLA-A, SYNTHETIC PEPTIDE 
4uq3:C     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-A0201 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE  |   IMMUNE SYSTEM, AZOBENZENE, HLA-A, SYNTHETIC PEPTIDE 
3pqy:A     (MET5) to   (LEU160)  CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224  |   H2DB, INFLUENZA, TCR, T CELL, PA EPITOPE, REPERTOIRE, VIRAL IMMUNITY, CHIMERIC TCR, IMMUNE SYSTEM 
5im7:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION  |   HLA, HIV, QW9, IMMUNE SYSTEM 
3pwj:A     (TYR7) to   (ASN174)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L,I9V) PEPTIDE VARIANT  |   HUD ANTIGEN, TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING 
3pwl:A     (TYR7) to   (ASN174)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE  |   TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING 
3pwl:D     (GLY1) to   (ASN174)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE  |   TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING 
3pwn:A     (GLY1) to   (ASN174)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT  |   TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, G2L MUTATION, PROTEIN BINDING 
3pwn:D     (GLY1) to   (ASN174)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT  |   TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, G2L MUTATION, PROTEIN BINDING 
3pwp:A     (TYR7) to   (GLY175)  THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE  |   TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING 
5inc:A     (SER2) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION  |   HLA, HIV, QW9_S3T, IMMUNE SYSTEM 
5inc:C     (GLY1) to   (LEU163)  CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION  |   HLA, HIV, QW9_S3T, IMMUNE SYSTEM 
5iro:A     (SER2) to   (GLU173)  CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 4 E3- 19K PROTEIN AND MHC CLASS MOLECULE HLA-A2/TAX  |   AD4 E3-19K-HLA-A2 COMPLEX, IMMUNE EVASION FUNCTION, MHC CLASS I MOLECULE, IMMUNE SYSTEM-TRANSCRIPTION COMPLEX 
5iro:I     (SER2) to   (ASN174)  CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 4 E3- 19K PROTEIN AND MHC CLASS MOLECULE HLA-A2/TAX  |   AD4 E3-19K-HLA-A2 COMPLEX, IMMUNE EVASION FUNCTION, MHC CLASS I MOLECULE, IMMUNE SYSTEM-TRANSCRIPTION COMPLEX 
4eup:D     (GLY1) to   (GLY175)  THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE  |   NONAPEPTIDE, MHC CLASS I, CROSS-REACTIVITY, MELANOMA, CANCER, IMMUNE SYSTEM 
4eup:A     (TYR7) to   (GLU173)  THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE  |   NONAPEPTIDE, MHC CLASS I, CROSS-REACTIVITY, MELANOMA, CANCER, IMMUNE SYSTEM 
3qdg:A     (GLY1) to   (LYS176)  THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE  |   MART-1 PEPTIDE, DECAPEPTIDE, MHC CLASS I, HLA-A2, TCR DMF5, CROSS- REACTIVITY, MELANOMA, CANCER, IMMUNE SYSTEM 
3qdj:A     (GLY1) to   (LYS176)  THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE  |   MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR DMF5, TCR DMF4, CROSS-REACTIVITY, CANCER, MELANOMA, IMMUNE SYSTEM 
3qfd:A     (TYR7) to   (ASN174)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH MART-1(27-35) NONAMERIC PEPTIDE  |   MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, MELANOMA, IMMUNE SYSTEM 
3qfd:D     (TYR7) to   (ASN174)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH MART-1(27-35) NONAMERIC PEPTIDE  |   MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, MELANOMA, IMMUNE SYSTEM 
5j6h:A     (SER2) to   (LEU160)  RECOGNITION OF THE MHC CLASS IB MOLECULE H2-Q10 BY THE NATURAL KILLER CELL RECEPTOR LY49C  |   IMMUNE SYSTEM 
4f7m:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PA (649-658)  |   HLA-A*2402, INFLUENZA A VIRUS, 2009 H1N1, HLA-A3 SUPERTYPE, IMMUNE SYSTEM 
4f7m:D     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PA (649-658)  |   HLA-A*2402, INFLUENZA A VIRUS, 2009 H1N1, HLA-A3 SUPERTYPE, IMMUNE SYSTEM 
4f7p:A     (GLY1) to   (LEU160)  CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009H1N1 PB1 (496-505)  |   HLA-A*2402, 2009H1N1, HLA-A3 SUPERTYPE, CROSS ALLELE RECOGNITION, IMMUNE SYSTEM 
4f7t:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PB1 (498-505)  |   HLA-A*2402, 2009H1N1, HLA-A3 SUPERTYPE, CROSS-ALLELE RECOGNITION, IMMUNE SYSTEM 
4f7t:D     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PB1 (498-505)  |   HLA-A*2402, 2009H1N1, HLA-A3 SUPERTYPE, CROSS-ALLELE RECOGNITION, IMMUNE SYSTEM 
3qq3:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF SWINE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SLA-1 0401 AND IDENTIFICATION OF 2009 PANDEMIC SWINE-ORIGIN INFLUENZA A H1N1 VIRUS CYTOTOXIC T LYMPHOCYTE EPITOPE PEPTIDES  |   SWINE MHC CLASS 1, SLA-1*0401, EPITOPE OF INFLUENZA VIRUS, IMMUNE SYSTEM 
3qq3:D     (LEU5) to   (MET174)  CRYSTAL STRUCTURE OF SWINE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SLA-1 0401 AND IDENTIFICATION OF 2009 PANDEMIC SWINE-ORIGIN INFLUENZA A H1N1 VIRUS CYTOTOXIC T LYMPHOCYTE EPITOPE PEPTIDES  |   SWINE MHC CLASS 1, SLA-1*0401, EPITOPE OF INFLUENZA VIRUS, IMMUNE SYSTEM 
3qq4:A     (GLY1) to   (MET174)  CRYSTAL STRUCTURE OF SWINE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SLA-1 0401 AND IDENTIFICATION OF 2009 PANDEMIC SWINE-ORIGIN INFLUENZA A H1N1 VIRUS CYTOTOXIC T LYMPHOCYTE EPITOPE PEPTIDES  |   SWINE MHC CLASS 1, SLA-1*0401, EPITOPE OF EBOLA VIRUS, IMMUNE SYSTEM 
3qzw:A     (GLY1) to   (GLY162)  PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402  |   IMMUNOGLOBULIN FAMILY, IMMUNE SYSTEM, CORECEPTOR 
3qzw:D     (GLY1) to   (GLY162)  PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402  |   IMMUNOGLOBULIN FAMILY, IMMUNE SYSTEM, CORECEPTOR 
3rew:D     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF AN LMP2A-DERIVED PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2  |   MHC CLASS I, TUMOUR ANTIGEN TARGETING, IMMUNE SYSTEM, HLA-A2, EPSTEIN BARR VIRUS, ALLOREACTIVITY, GLYCOPROTEIN, IMMUNE RESPONSE, MHC I, IMMUNOGLOBULIN DOMAIN 
4ftv:A     (TYR7) to   (GLY175)  THE COMPLEX BETWEEN THE HIGH AFFINITY VERSION OF A6 TCR (A6C134) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TAX NONAMERIC PEPTIDE  |   TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, HIGH AFFINITY, C134, IMMUNE SYSTEM 
4g8g:A     (TYR7) to   (GLU161)  CRYSTAL STRUCTURE OF C12C TCR-HA B2705-KK10  |   TCR, T CELL, HLA B*2705, KK10, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM 
4g9f:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF C12C TCR-HLAB2705-KK10-L6M  |   TCR, T CELL, HLA B*2705, KK10, KK10-L6M, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM 
4gkn:D     (GLY1) to   (ASN174)  A2-MHC COMPLEX CARRYING FATGIGIITV  |   MAJOR HISTOCOMPATIBILITY COMPLEX, T-CELL RECEPTOR, IMMUNO, IMMUNOGLOBULIN, RECOGNITION, MHC, TCR, IMMUNE SYSTEM 
5swq:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH NA231, AN INFLUENZA EPITOPE  |   HLA-A*02:01, CROSS-REACTIVITY, HETEROLOGOUS IMMUNITY, TCR, T CELL, IMMUNE SYSTEM 
1a1m:A     (GLY1) to   (GLY175)  MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2  |   MAJOR HISTOCOMPATIBILITY ANTIGEN, MHC, HLA, HLA-B53, HIV, COMPLEX (ANTIGEN/PEPTIDE) 
2ak4:A     (SER2) to   (LYS176)  CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE  |   T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM 
2ak4:F     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE  |   T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM 
2ak4:K     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE  |   T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM 
2ak4:Q     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE  |   T CELL RECEPTOR, BULGED EPITOPES, PMHC/TCR COMPLEX, IMMUNE SYSTEM 
1a9b:A     (SER2) to   (GLY175)  DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA- B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS  |   MHC CLASS I, HISTOCOMPATIBILITY COMPLEX, HLA B3501, COMPLEX (MHC CLASS I/PEPTIDE) 
1a9b:D     (SER2) to   (GLY175)  DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA- B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS  |   MHC CLASS I, HISTOCOMPATIBILITY COMPLEX, HLA B3501, COMPLEX (MHC CLASS I/PEPTIDE) 
1agc:A     (SER2) to   (ASN174)  ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYQL-7Q MUTATION)  |   HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX 
1agf:A     (SER2) to   (ASN174)  ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKRYKL-5R MUTATION)  |   HLA B8, HIV, MHC CLASS I, HISTOCOMPATIBILITY COMPLEX 
2axg:A     (SER2) to   (GLY175)  THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION  |   IMMUNE RESPONSE, PMHC, IMMUNE SYSTEM/GENE REGULATION COMPLEX 
2bck:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASE PEPTIDE  |   IMMUNOGLOBULIN DOMAINS, BETA BARRELS, MHC FOLD, IMMUNE SYSTEM 
2bck:D     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASE PEPTIDE  |   IMMUNOGLOBULIN DOMAINS, BETA BARRELS, MHC FOLD, IMMUNE SYSTEM 
2bnr:A     (GLY1) to   (LEU160)  STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES  |   IMMUNE SYSTEM/RECEPTOR, IMMUNE SYSTEM/RECEPTOR/COMPLEX, TCR, MHC, IMMUNODOMINANCE, FLU, COMPLEX, PEPTIDE, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, POLYMORPHISM, T-CELL, RECEPTOR, SUPERAGONIST PEPTIDE T-CELL VACCINES 
2bvq:A     (SER2) to   (ASN174)  STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION  |   GLYCOPROTEIN/PEPTIDE, MHC, HLA-B57, LTNP HIV-1, GLYCOPROTEIN/PEPTIDE COMPLEX, MHC I, POLYMORPHISM, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE 
1of2:A     (SER2) to   (GLY175)  CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)  |   IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA (HUMAN LEUKOCYTE ANTIGEN) 
3fqr:A     (GLY1) to   (ASN174)  PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES  |   IMMUNE SYSTEM, PHOSPHORYLATION, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, CANCER, TCR, SELF-EPITOPE 
3gjf:A     (GLY1) to   (LYS176)  RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES  |   MHC, PEPTIDE, ANTIBODY, DISULFIDE BOND, GLYCOPROTEIN, HOST- VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3gsq:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5S PEPTIDE VARIANT  |   HLA, HUMAN CYTOMEGALOVIRUS, PP65, T CELL RECEPTOR (TCR), IMMUNE RESPONSE, PUBLIC RESPONSE, IMMUNODOMINANCE, RESTRAINED RESPONSE, HOST-VIRUS INTERACTION, MEMBRANE, MHC I, POLYMORPHISM, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
4jfp:A     (TYR7) to   (ASN174)  A2 HLA COMPLEX WITH G4A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE  |   IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY 
4jfp:D     (GLY1) to   (ASN174)  A2 HLA COMPLEX WITH G4A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE  |   IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY 
4jrx:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF CA5 TCR-HLA B*3505-LPEP COMPLEX  |   TCR, T CELL, HLA B*3508, LPEP, EBV, ALLOREACTIVITY, IMMUNE SYSTEM 
1qr1:A     (TYR7) to   (ASN174)  POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE  |   PEPTIDE-BINDING SUPERDOMAIN, IMMUNE SYSTEM 
1qr1:D     (TYR7) to   (ASN174)  POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE  |   PEPTIDE-BINDING SUPERDOMAIN, IMMUNE SYSTEM 
1qrn:A     (TYR7) to   (LYS176)  CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A  |   HUMAN TCR/PEPTIDE/MHC COMPLEX, HLA-A2, HTLV-1, TAX, TCR, T CELL RECEPTOR, IMMUNE SYSTEM 
3h7b:A     (GLY1) to   (ASN174)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE TEL1P PEPTIDE  |   TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3h7b:D     (GLY1) to   (LYS176)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE TEL1P PEPTIDE  |   TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3hg1:A     (GLY1) to   (ASN174)  GERMLINE-GOVERNED RECOGNITION OF A CANCER EPITOPE BY AN IMMUNODOMINANT HUMAN T CELL RECEPTOR  |   T-CELL RECEPTOR, CDR3, PHAGE DISPLAY, MELAN-1, MART-1, IMMUNE SYSTEM, DISULFIDE BOND, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED 
2v2w:A     (GLY1) to   (LYS176)  T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT  |   IMMUNOGLOBULIN DOMAIN, COMPLEX (ANTIGEN-PEPTIDE), TCR, HIV, MHC, AIDS, MHC I, HLA-A2, MEMBRANE, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE SYSTEM, COMPLEX (ANTIGEN/PEPTIDE), UBL CONJUGATION, IMMUNE RESPONSE, DISEASE MUTATION, POLYMORPHISM, GLYCOPROTEIN, TRANSMEMBRANE 
2v2w:D     (GLY1) to   (LYS176)  T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT  |   IMMUNOGLOBULIN DOMAIN, COMPLEX (ANTIGEN-PEPTIDE), TCR, HIV, MHC, AIDS, MHC I, HLA-A2, MEMBRANE, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE SYSTEM, COMPLEX (ANTIGEN/PEPTIDE), UBL CONJUGATION, IMMUNE RESPONSE, DISEASE MUTATION, POLYMORPHISM, GLYCOPROTEIN, TRANSMEMBRANE 
3hla:A     (GLY1) to   (GLY175)  HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2.1  |   HISTOCOMPATIBILITY ANTIGEN 
1frt:A     (LEU7) to   (THR159)  CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC  |   COMPLEX (RECEPTOR-IMMUNOGLOBULIN), COMPLEX (RECEPTOR-IMMUNOGLOBULIN) COMPLEX 
3upr:A     (SER2) to   (GLY162)  HLA-B*57:01 COMPLEXED TO PEP-V AND ABACAVIR  |   HLA-B*57:01, MHC, ANTIGEN PRESENTING CELL, T-CELL RECEPTOR, HUMAN LEUKOCYTE ANTIGEN, DRUG HYPERSENSITIVITY, ABACAVIR HYPERSENSITIVITY, REPERTOIRE-ALTERING SMALL MOLECULE, IMMUNE RESPONSE, IMMUNOGLOBULIN- LIKE BETA-SANDWICH, IMMUNE SYSTEM 
3upr:C     (SER2) to   (GLY175)  HLA-B*57:01 COMPLEXED TO PEP-V AND ABACAVIR  |   HLA-B*57:01, MHC, ANTIGEN PRESENTING CELL, T-CELL RECEPTOR, HUMAN LEUKOCYTE ANTIGEN, DRUG HYPERSENSITIVITY, ABACAVIR HYPERSENSITIVITY, REPERTOIRE-ALTERING SMALL MOLECULE, IMMUNE RESPONSE, IMMUNOGLOBULIN- LIKE BETA-SANDWICH, IMMUNE SYSTEM 
3utq:A     (GLY1) to   (ASN174)  HUMAN HLA-A*0201-ALWGPDPAAA  |   MAJOR HISTOCOMPATIBILITY COMPLEX, HUMAN LEUKOCYTE ANTIGEN, TYPE I DIABETES, IMMUNE SYSTEM 
1s7v:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS  |   LCMV, MHC CLASS I, IMMUNE ESCAPE, IMMUNE SYSTEM 
1t1y:A     (GLY1) to   (ASN174)  STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-5V  |   CTL, CYTOTOXIC T LYMPHOCYTES, HIV, HUMAN IMMUNODEFICIENCY VIRUS, MHC, MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, PEPTIDE MHC COMPLEX, RMSD, ROOT-MEAN-SQUARED DEVIATION, SIV, SIMIAN IMMUNODEFICIENCY VIRUS, TCR, T-CELL RECEPTOR, IMMUNE SYSTEM 
4l29:A     (GLY1) to   (LYS176)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
4l29:E     (GLY1) to   (LYS176)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
4l29:G     (GLY1) to   (ASN174)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
4l29:I     (GLY1) to   (ASN174)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
4l29:K     (GLY1) to   (ALA158)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
4l29:M     (GLY1) to   (ASN174)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
4l29:U     (GLY1) to   (GLY175)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
4l29:Y     (GLY1) to   (ASN174)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
4l29:a     (GLY1) to   (LYS176)  STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM 
2gj6:A     (TYR7) to   (ASN174)  THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE  |   HTLV-1 TAX PEPTIDE, HAPTENATED PEPTIDE, LYSINE-4-(3-INDOLYL)-BUTYRIC ACID, MHC CLASS I,HLA-A2, T-CELL RECEPTOR A6, IMMUNE SYSTEM 
4l3c:C     (GLY1) to   (ASN174)  STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION 
4l3c:E     (GLY1) to   (ASN174)  STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION 
4l3c:G     (GLY1) to   (ASN174)  STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION 
4l3c:M     (GLY1) to   (ASN174)  STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION 
4l3c:O     (GLY1) to   (LYS176)  STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION 
4l3c:Q     (GLY1) to   (LYS176)  STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION 
4l3c:S     (GLY1) to   (ASN174)  STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION 
4l3c:U     (GLY1) to   (ASN174)  STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION 
4l3c:Y     (GLY1) to   (ASN174)  STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION 
4l3c:a     (GLY1) to   (GLY175)  STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT  |   MHC, BETA-2 MICROGLOBULIN, HLA_A0201, NY-ESO1, D76N VARIANT, IMMUNGLOBULIN, BETA SANDWITCH, IMMUNE SYSTEM, AMYLOID AGGREGATION 
2gt9:D     (TYR7) to   (LYS176)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE DECAMERIC MELAN-A/MART- 1(26-35) PEPTIDE  |   MELAN-A/MART-1 PEPTIDE, DECAPEPTIDE, MHC CLASSI, HLA-A2, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM 
2gtw:D     (TYR7) to   (ASN174)  HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A27L SUBSTITUTION  |   MELAN-A/MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, A27L MUTATION, MELANOMA, CANCER VACCINES, IMMUNE SYSTEM 
1hsa:A     (SER2) to   (LYS176)  THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC  |   HISTOCOMPATIBILITY ANTIGEN 
1hsa:D     (SER2) to   (LYS176)  THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC  |   HISTOCOMPATIBILITY ANTIGEN 
2hjl:A     (SER2) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE  |   B57, HLA, HIV, IMMUNE SYSTEM 
1i1f:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y  |   HUMAN CLASS I MHC, HIV, IMMUNE SYSTEM 
1i1f:D     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y  |   HUMAN CLASS I MHC, HIV, IMMUNE SYSTEM 
1uxw:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS  |   IMMUNE SYSTEM-PEPTIDE COMPLEX, COMPLEX (ANTIGEN/PEPTIDE), IMMUNE SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2709 
1jf1:A     (TYR7) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A DECAMERIC ALTERED PEPTIDE LIGAND FROM THE MART-1/MELAN-A  |   HUMAN, TUMOR IMMUNITY, MELANOMA ANTIGEN, MHC, VACCINATION, MELANOMA, CLASS I, IMMUNE SYSTEM 
4ms8:A     (GLY1) to   (GLY175)  42F3 TCR PCPB9/H-2LD COMPLEX  |   IG, TCR MHC, IMMUNE SYSTEM 
3wuw:A     (SER2) to   (GLY175)  KIR3DL1 IN COMPLEX WITH HLA-B*57:01.I80T  |   IMMUNE RECEPTOR COMPLEX, PROTEIN BINDING 
4n0u:A     (HIS4) to   (PHE157)  TERNARY COMPLEX BETWEEN NEONATAL FC RECEPTOR, SERUM ALBUMIN AND FC  |   ALPHA/BETA, DNA BINDING PROTEIN 
5c0g:A     (GLY1) to   (ASN174)  HLA-A02 CARRYING YLGGPDFPTI  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
4nny:A     (SER2) to   (ASN174)  CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF PKD2 PHOSPHOPEPTIDE BOUND TO HLA-A2  |   NONPHOSPHORYLATED EPITOPE, PEPTIDE-MHC COMPLEX, MHC, POST TRANSLATIONAL MODIFICATION, PEPTIDE CONFORMATION, TUMOR IMMUNOLOGY, TUMOR ANTIGEN, IMMUNE SYSTEM-ANTIGEN COMPLEX 
2yez:A     (GLU1) to   (GLY172)  COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 10MER CHICKEN PEPTIDE  |   IMMUNE SYSTEM, BF21, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I 
3jts:A     (GLY1) to   (LYS176)  GY9-MAMU-A*02-HB2M  |   ALPHA HELIX, BETA SHEET, BETA BARREL, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, DISULFIDE BOND, GLYCATION, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3jts:G     (GLY1) to   (LYS176)  GY9-MAMU-A*02-HB2M  |   ALPHA HELIX, BETA SHEET, BETA BARREL, IMMUNE RESPONSE, MHC I, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, DISULFIDE BOND, GLYCATION, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3kpl:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN  |   HLA B*4402, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, IMMUNE SYSTEM 
3kpp:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN  |   HLA B*4405, ALLORECOGNITION, TCR RECOGNITION, SELF PEPTIDE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNE SYSTEM 
1ydp:A     (SER2) to   (ASN174)  1.9A CRYSTAL STRUCTURE OF HLA-G  |   IMMUNE SYSTEM 
3kxf:A     (SER2) to   (ASN174)  CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE 'RESTRICTION TRIAD' MUTANT HLA-B*3508-13MER  |   MHC, HLA, TCR, DISULFIDE BOND, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3kxf:K     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE 'RESTRICTION TRIAD' MUTANT HLA-B*3508-13MER  |   MHC, HLA, TCR, DISULFIDE BOND, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3kxf:I     (SER2) to   (ASN174)  CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE 'RESTRICTION TRIAD' MUTANT HLA-B*3508-13MER  |   MHC, HLA, TCR, DISULFIDE BOND, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
5def:A     (SER2) to   (GLY175)  CRYSTAL STRUCTURE OF B*27:04 COMPLEX BOUND TO THE PVIPR PEPTIDE  |   IMMUNE SYSTEM-COMPLEX, IMMUNE SYSTEM, MHC MAJOR HISTOCOMPATIBILITY COMPLEX), HLA- B*2704 
4pj5:A     (ARG1) to   (GLY172)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR  |   MR1, MAIT TCR, AC-6-FP, IMMUNE COMPLEX, IMMUNE SYSTEM 
4pj9:A     (ARG1) to   (GLY172)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRAJ20 TCR  |   MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM 
4pja:A     (ARG1) to   (GLY172)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR  |   MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM 
4pja:C     (ARG1) to   (LYS173)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR  |   MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM 
4prb:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-A4  |   HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM 
4prd:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-D5  |   HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM 
4prp:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:01-HPVG-Q5 COMPLEX  |   HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM 
3lkq:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1977 STRAIN  |   HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3lks:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1980 STRAIN  |   HLA B*3501, NP418 EPITOPE, INFLUENZA, SWINE-FLU, T CELL IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3bhb:A     (GLY1) to   (GLU173)  CRYSTAL STRUCTURE OF KMD PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2  |   PHOSPHOSERINE, PHOSPHOPEPTIDE, MHC, HLA-A2, ANCHOR RESIDUE, TUMOR ANTIGEN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, IMMUNOGLOBULIN DOMAIN, PHOSPHOPROTEIN, IMMUNE SYSTEM 
5eu6:A     (GLY1) to   (ASN174)  HLA CLASS I ANTIGEN  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
3mro:A     (GLY1) to   (LEU160)  CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN- A MART1 DECAPEPTIDE VARIANT  |   MHC CLASS I, HLA, IMMUNE SYSTEM, IMMUNE RESPONSE, DECAPEPTIDE, TUMORAL PEPTIDE, MELAN-A, MART1 
3mv8:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF THE TK3-GLN55HIS TCR IN COMPLEX WITH HLA- B*3501/HPVG  |   HLA B*3501, EBV, TCR, TCRPMHC COMPLEX, HPVG, TCR POLYMORPHISM, IMMUNE SYSTEM 
3bwa:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 8- MER PEPTIDE FROM THE PP65 PROTEIN  |   HLA B*3508, CRYSTAL STRUCTURE, HCMV, PP65, IMMUNOLOGY, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, PHOSPHOPROTEIN, TEGUMENT PROTEIN, VIRAL MATRIX PROTEIN, VIRION, IMMUNE SYSTEM 
3bzf:C     (GLY1) to   (LEU160)  THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E  |   MHC FOLD, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, POLYMORPHISM, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, HOST-VIRUS INTERACTION, UBL CONJUGATION, IMMUNE SYSTEM 
3dmm:A     (SER2) to   (ASN174)  CRYSTAL STRUCTURE OF THE CD8 ALPHA BETA/H-2DD COMPLEX  |   T CELL CO-RECEPTOR CD8AB MHC COMPLEX, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, ENVELOPE PROTEIN, ALTERNATIVE SPLICING, POLYMORPHISM, IMMUNE SYSTEM 
3dx7:A     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA-B*4403 PRESENTING 10MER EBV ANTIGEN  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
5hhm:A     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L  |   HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM 
5hhm:F     (GLY1) to   (LYS176)  CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L  |   HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM 
5hhp:A     (GLY1) to   (ASN174)  CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-G4E  |   HLA A*0201, INFLUENZA, M1, TCR, T CELL, IMMUNE SYSTEM 
5ind:C     (GLY1) to   (GLY175)  CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION  |   HLA, HIV, QW9_E5D, IMMUNE SYSTEM 
3qeq:A     (TYR7) to   (ASN174)  THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE  |   MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR DMF5, TCR DMF4, CROSS-REACTIVITY, CANCER, MELANOMA, IMMUNE SYSTEM 
4g8i:A     (TYR7) to   (ASN174)  CRYSTAL STRUCTURE OF HLA B2705-KK10-L6M  |   TCR, T CELL, HLA B*2705, KK10, KK10-L6M, HIV, IMMUNE ESCAPE, IMMUNE SYSTEM